Device and method for cancer detection, diagnosis and treatment guidance using active thermal imaging

ABSTRACT

The present invention discloses means and methods for detecting irregularities in the cells throughout a healthy tissue. The method generally relates to cancer detection, diagnosis and treatment, and more specifically pertains to detection, diagnosis and treatment guidance of cancerous or precancerous conditions through the use of thermal imaging technology and analysis.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a Continuation-in-part of PCT Patent Application No.PCT/IL2015/050392 filed on Apr. 13, 2015, which claims the benefit ofpriority of U.S. Provisional Application No. 62/110,615 filed on Feb. 2,2015 and U.S. Provisional Application No. 61/978,901 filed Apr. 13,2014. The contents of the above applications are all incorporated byreference as if fully set forth herein in their entirety.

FIELD OF THE INVENTION

The present invention relates to cancer detection and diagnosis, andmore specifically the present invention relates to cancer detection anddiagnosis through the use of thermal imaging technology.

BACKGROUND OF THE INVENTION

Tumor cells are distinct from their surrounding normal tissue by severalproperties, one of which is a thermo-physical property referred to asthermal diffusivity, which is expected to be different in cancerouscells compared to healthy cells. Thermal diffusivity is the combinedproperty of density, heat capacity, thermal conductivity, bloodperfusion and metabolic rate which are expected to be noticeablydifferent in cancer cells. Importantly, even precancerous tissues orvery young tumors appear to have distinct thermal diffusivity propertiesdue to an enlarged nucleus, elevated crowdedness and more.

Lung cancer is considered the most deadly cancers in men and womenworldwide. Lung cancer is the leading cause of cancer death among bothmen and women in the United States.

Statistical data regarding the extent of lung cancer states that lungcancer results in about 1.6 million deaths a year worldwide, being theleading cause of cancer death, at a total of 27% of all cancer relateddeaths. In the U.S. alone 228,190 new cases are diagnosed, and 160,000deaths occur annually. In Israel 1,900 new cases are diagnosed and 1,600deaths occur annually. Only 5% of lung cancers cases are diagnosed instages that allow healing.

This extremely low survival rate of lung cancer is not due to lungtumors being more aggressive than other malignant tumors types, but infact is due to the lack of early detection.

Since the lung contains no ‘pain sensing’ mechanism and its gas volumeis much greater than its tissue volume, a tumor would hardly be noticedat early stages. Usually when the patient starts feeling any discomfortand turns to a physician, the tumor will already have exceeded thetreatable size. Therefore breathing difficulties and coughing whichusually leads to the diagnosis of the cancer means the tumor is largeenough to be noticed and is probably untreatable. At this stage thecancer is progressive and usually metastatic and a targeted healingtherapy cannot be considered, resulting in a five year survival ratewhich is very low.

In order to increase survival rate, many screening programs in the USuse low dose CT. Screening reduced lung cancer deaths by 20%. But, while25% of the tests are positive, 96% of all positive results are false anddo not result in lung cancer diagnosis. About 30% of people withpositive CT will go for a biopsy and only 20% of them will find out theyhave lung cancer.

These false positives lead to unnecessary biopsies and unnecessarytreatment for healthy person. Therefore, a ‘decision support’ system, toinform a clinician whether the positive CT is a cancer and requiresfurther investigation, would be of considerable utility. Such a systempreferably provides immediate results, does not involve radiation risksand is independent of the need for an expert's eye. Preferably, such atest is computerized and automatic with no need for a long, expensiveanalysis stage.

In addition, oncologists treating the cancer have great difficulty inmonitoring the treatment progress, and even cataloging the differentstages of the disease. Many times, after a relatively long treatingperiod, the physician would find the treatment had little to no effect.Treatment methods would then be changed, losing valuable time. In othercases cancer cells would successfully be destroyed, and turn intonecrotic cells, however, traditional scans would not differentiate themfrom cancer cells. Usually in this case, an invasive lung biopsy isneeded.

According to the World Health Organization (WHO), cervical cancer is thesecond most commonly prevalent cancer and the third greatest cause ofdeath in women, with 530,000 new cases discovered each year.

Increasing incidences of weakened immune system, rapid spread of humanpapillomavirus (HPV) infection among the female population and long-termuse of oral contraceptive pills are the primary factors responsible forthe growth of cervical cancer.

Currently, cervical cancer screening includes a cytology-basedscreening, known as the Pap test or Pap smear. The main purpose ofscreening with the Pap test is to detect precancerous abnormal cellsthat may develop into cancer if left untreated, specifically CervicalIntraepithelial Neoplasia (CIN). In regularly screened populations, thePap test identifies most abnormal cells before they become cancer.However, the Pap test should be taken with caution, as it isapproximated that test incidence of false negatives can be as high as20%-45%. Moreover, Pap test is expensive and requires 14-30 days ofwaiting for the cytology testing.

U.S. Pat. No. 8,774,902 discloses a device and method to diagnose aninternal abnormality in a living subject by sensing a passivelyoccurring electromagnetic radiation signal associated with theabnormality and inside an orifice of the subject, and U.S. Pat. No.7,513,876 discloses a system for passively detecting thermaldiscrepancies in vessel walls. However, the use of passively occurringradiation only renders '902 to be incompetent in detecting minordifferences in cell structure, which are already found in theprecancerous stage.

U.S. Pat. No. 8,864,669 discloses a method for detecting abnormal tissueusing ultrasound backscattered from the background. The detection ismanifested through different tissues absorbing ultrasound differently.

U.S. Pat. No. 8,923,954 discloses an IR detection system for identifyingmalignant tumors by identifying areas of increased metabolic activity,and by assuming that malignant tumors have increased metabolic activitydue to increased blood supply. However, patent '954 only identifiestumors which have grown in mass to such extent as to provide evidence ofincreased metabolic activity and blood supply.

US patent publication number US2013/0116573 and US Patent Publicationnumber US2011/0230942 disclose a thermal imaging system to scan at leasta section of a surface of a subject under observation, using both ageometrical scanning system and a thermal (IR) scanning system. A dataprocessing system receives data from the geometrical scanning system,constructs a surface map of the section of the surface under observationand identifies geometrical markers on the surface map based on the datafrom the geometrical scanning system. The data processing system alsoreceives data over a recovery time from the IR imaging system andconstructs a thermal map of the section of the surface, identifyingthermal markers on the thermal map based on the data from the infraredimaging system. The two maps are then registered based on acorrespondence between at least some of the geometrical and thermalmarkers and the locations of lesions at the surface can be determinedfrom the surface temperature profile as shown in the registered image.However, in the above documents, to Herman, the skin surface is cooledby application of cold fluid to a region of the surface, so that Hermancan only identify lesions at or very near the surface.

Therefore, a long felt need still exists for a screening system andmethod which will provide early pre-cancerous diagnosis.

SUMMARY OF THE INVENTION

Therefore, detection of cancer cells using a thermal diffusivity imagingmethod is disclosed.

It is thus an object of the present invention to disclose a method fordetecting and diagnosing of at least one irregularity in an examinedtissue, characterized by steps of:

-   -   actively thermomodulating at least a portion of said examined        tissue, said active thermomodulation selected from a group        consisting of heating, cooling and any combination thereof, said        active thermomodulation applied according to a pre-determined        protocol selected from a group consisting of: in a continuous        manner, in a pulsed manner and any combination thereof;    -   collecting time-resolved thermal data at predetermined time        intervals over time t, of a plurality of coordinated locations        of at least a portion of said examined tissue;    -   calculating according to said time-resolved thermal data, a        thermal transfer index, I, for each of said plurality of        coordinated locations;    -   wherein at least one of the following is being held true:    -   if, for at least one of said plurality of coordinated locations,        said I is greater than a predetermined value I_(irr),        determining tissue at said least one coordinated location as        irregular;    -   if, for at least one of said plurality of coordinated locations,        a ratio between said I and a predetermined I-scale is greater        than a predetermined value I_(irr), determining tissue at said        least one coordinated location as irregular;    -   if, for at least two of said plurality of coordinated locations,        a ratio between a first I_(first), of a first coordinated        location and a second I_(second) of a second coordinated        location is greater than a predetermined value I_(irr),        determining tissue at said first coordinated location as        irregular    -   further wherein said processor is configured to generate a        three-dimensional visual presentation of said coordinated        locations according to said I or an inferential thereof.

It is thus another object of the present invention to disclose themethod as described above, further comprising a step of defining said Iin a manner selected from:

-   -   according to the following formula:        T=a+b*exp(−I*t)    -   where T is temperature at said time t and a and b are constants;    -   according to the following formula:

${\rho C\frac{\partial T}{\partial t}} = {{\nabla\left( {k{\nabla T}} \right)} + q + A_{0} - {b\left( {T - T_{b}} \right)}}$

-   -   where:

$q\left\lbrack \frac{W}{m^{3}} \right\rbrack$is an external heat source;

$A_{0}\left\lbrack \frac{W}{m^{3}} \right\rbrack$is a metabolic heat source;

$b\left\lbrack \frac{W}{m^{3}\mspace{11mu}{^\circ}\;{C.}} \right\rbrack$is a heat loss due to blood perfusion; T_(b) [° C.] is bloodtemperature;

-   -   T [° C.] is temperature;

$\rho\left\lbrack \frac{kg}{m^{3}} \right\rbrack$is density;

$C_{p}\left\lbrack \frac{J}{{kg}\mspace{11mu}{^\circ}\;{C.}} \right\rbrack$is heat capacity; and

$k\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$is thermal conductivity factor;

-   -   from a thermal conductivity coefficient, from a thermal        diffusion coefficient, from a heat capacity, from a density,        from a heat loss due to blood perfusion, from a blood        temperature, from a heat convection index, from a metabolic heat        source and any combination thereof.

It is thus another object of the present invention to disclose themethod as described above, further comprising at least one of thefollowing steps:

-   -   selecting said at least one irregularity from a group consisting        of a malignant tumor, a precancerous tumor, a benign tumor, an        infection, pneumonia, a necrotic cell, a blood clot and any        combination thereof;    -   selecting said examined tissue from a group consisting of lung        tissue, skin, cervical tissue, ear tissue, nose tissue, throat        tissue, oral tissue, esophageal tissue, stomach tissue,        intestinal tissue, colon tissue, rectal tissue, kidney tissue,        uterine tissue, urinary tract tissue, bladder tissue, prostate        tissue, eye tissue, and any combination thereof; and    -   selecting said time interval t to be in a range from about 10 ns        to about 10 min.

It is thus another object of the present invention to disclose themethod as described above, further comprising steps of collecting saidthermal data using at least one sensor and of selecting said at leastone sensor from a group consisting of: an IR sensor, a mercury-in-glassthermometer, pill thermometer, liquid crystal thermometer, thermocouple,thermistor, resistance temperature detector, silicon bandgap temperaturesensor and any combination thereof.

It is thus another object of the present invention to disclose themethod as described above, further comprising at least one of thefollowing steps:

-   -   producing at least one heat diffusion image of at least a        portion of said examined tissue prior to said active        thermomodulation;    -   image processing said at least one heat diffusion image by at        least one object recognition module, thereby identifying        coordinated locations suspected of containing at least one said        irregularity; and    -   providing at least one spatial positioner selected from a group        consisting of a visible light imaging means, a CCD camera, an        ultrasound scanner, a thermal camera, a laser rangefinder and        any combination thereof, and correlating said at least one heat        diffusion image and at least one image from said at least one        spatial positioner.

It is thus another object of the present invention to disclose themethod as described above, further comprising a providing anormalization step, at least one of the following being held true:

-   -   said normalizing step comprises normalizing said I to a        predetermined scale, a higher value on said scale indicating a        higher severity of the medical condition of said at least one        irregularity;    -   said normalizing step is selected from a group consisting of        correcting to ambient temperature, correcting to ambient        humidity, correcting to ambient electromagnetic radiation and        any combination thereof;    -   said normalizing step is selected from a group consisting of        correcting for ambient temperature, correcting for ambient        humidity, correcting for ambient electromagnetic radiation and        any combination thereof; and    -   said heat transfer index is normalized with patient parameters        selected from a group consisting of sex, age, smoking habits,        drinking habits, number of births, height, weight, blood        pressure, diabetes state, medical history, relatives medical        history, patient's previous heat transfer index and any        combination thereof.

It is thus another object of the present invention to disclose themethod as described above, further comprising steps of selecting saidactive thermomodulation from a group consisting of advecting heat,convecting heat, conducting heat, irradiating and any combinationthereof; and of selecting said active thermomodulation device from agroup consisting of hot fluid inhalation, cold fluid inhalation, hotfluid application, cold fluid application, halogen lamp exposure, coldfluid xenon lamp exposure, flash lamp exposure, incandescent lampexposure, IR emission, electromagnetic vibration heating, mechanicalvibration heating, positioning a heatable solid, positioning a coolablesolid, positioning a heatable patch, positioning a coolable patch,pharmaceutical temperature modification, chemically induced heating,chemically induced cooling and any combination thereof.

It is thus another object of the present invention to disclose a systemfor detecting and diagnosing at least one irregularity in an examinedtissue, comprising:

-   -   an active thermomodulator configured to apply to at least a        portion of said examined tissue a member of a group consisting        of: heating cooling and any combination thereof, said active        thermomodulation applicable according to a pre-determined        protocol selected from a group consisting of: in a continuous        manner, in a pulsed manner and any combination thereof;    -   at least one thermal sensor configured to provide at least one        signal related to temperature in at least a part of said at        least a portion of said examined tissue; and    -   a processor configured to execute instructions comprising:    -   collect time-resolved thermal data, at predetermined intervals        over time t, of a plurality of coordinated locations of at least        a portion of said examined tissue by conversion of said signal        from said at least one thermal sensor to time-resolved and        spatially-resolved thermal data; and    -   calculate, according to said time-resolved thermal data, a        thermal transfer index, I, for each of said plurality of        coordinated locations;    -   wherein at least one of the following is being held true:    -   if, for at least one of said plurality of coordinated locations,        said I is greater than a predetermined value I_(irr), tissue at        said least one coordinated location is determinable as        irregular;    -   if, for at least one of said plurality of coordinated locations,        a ratio between said I and a predetermined I-scale is greater        than a predetermined value I_(irr), tissue at said least one        coordinated location is determinable as irregular;    -   if, for at least two of said plurality of coordinated locations,        a ratio between a first I_(first) of a first coordinated        location and a second I_(second) of a second coordinated        location is greater than a predetermined value I_(irr), tissue        at said first coordinated location is determinable as irregular;    -   further wherein said processor is configured to generate at        least one of a group consisting of a two-dimensional thermal map        or a three-dimensional thermal diffusion image of said at least        a portion of said examined tissue.

It is thus another object of the present invention to disclose thesystem as described above, wherein said I is definable in a mannerselected from:

-   -   according to the following formula:        T=a+b*exp(−I*t)    -   where T is temperature at said time t and a and b are constants;    -   according to the following formula:

${\rho C\frac{\partial T}{\partial t}} = {{\nabla\left( {k{\nabla T}} \right)} + q + A_{0} - {b\left( {T - T_{b}} \right)}}$

-   -   where:

$q\left\lbrack \frac{W}{m^{3}} \right\rbrack$is an external heat source;

$A_{0}\left\lbrack \frac{W}{m^{3}} \right\rbrack$is a metabolic heat source;

$b\left\lbrack \frac{W}{m^{3}{{{^\circ}C}.}} \right\rbrack$is a heat loss due to blood perfusion; T_(b) [° C.] is bloodtemperature;

-   -   T [° C.] is temperature;

$\rho\left\lbrack \frac{kg}{m^{3}} \right\rbrack$is density;

$C_{p}\left\lbrack \frac{J}{{kg}\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$is heat capacity; and

$k\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$is thermal conductivity factor;

-   -   from a thermal conductivity coefficient, from a thermal        diffusion coefficient, from a heat capacity, from a density,        from a heat loss due to blood perfusion, from a blood        temperature, from a heat convection index, from a metabolic heat        source and any combination thereof.

It is thus another object of the present invention to disclose thesystem as described above, wherein at least one of the following is heldtrue:

-   -   said at least one irregularity is selected from a group        consisting of a malignant tumor, a precancerous tumor, a benign        tumor, an infection, pneumonia, a necrotic cell, a blood clot        and any combination thereof;    -   said examined tissue is selected from a group consisting of lung        tissue, skin, cervical tissue, ear tissue, nose tissue, throat        tissue, oral tissue, esophageal tissue, stomach tissue,        intestinal tissue, colon tissue, rectal tissue, kidney tissue,        uterine tissue, urinary tract tissue, bladder tissue, prostate        tissue, eye tissue, and any combination thereof; and    -   said time t is selected to be in a range from about 10 ns to        about 10 min.

It is thus another object of the present invention to disclose thesystem as described above, wherein said at least one sensor is selectedfrom a group consisting of: an IR sensor, a mercury-in-glassthermometer, pill thermometer, liquid crystal thermometer, thermocouple,thermistor, resistance temperature detector, silicon bandgap temperaturesensor and any combination thereof.

It is thus another object of the present invention to disclose thesystem as described above, wherein at least one of the following is heldtrue:

-   -   at least one heat diffusion image of at least a portion of said        examined tissue is producible prior to said active        thermomodulation;    -   at least one coordinated location suspected of containing at        least one irregularity is identifiable by means of image        processing of said at least one heat diffusion image by at least        one object recognition module; and    -   said system additionally comprises at least one spatial        positioner selected from a group consisting of: a visible light        imaging means, a CCD camera, an ultrasound scanner, a thermal        camera, a laser rangefinder and any combination thereof, and        said processor additionally comprises instructions configured to        correlate said at least one heat diffusion image and at least        one image from said at least one spatial positioner.

It is thus another object of the present invention to disclose thesystem as described above, wherein said computer program additionallycomprises instructions to provide a normalization step, at least one ofthe following being held true:

-   -   said normalizing step comprises normalizing said I to a        predetermined scale, a higher value on said scale indicating a        higher severity of the medical condition of said at least one        irregularity;    -   said normalizing step is selected from a group consisting of        correcting to ambient temperature, correcting to ambient        humidity, correcting to ambient electromagnetic radiation and        any combination thereof;    -   said normalizing step is selected from a group consisting of        correcting for ambient temperature, correcting for ambient        humidity, correcting for ambient electromagnetic radiation and        any combination thereof; and    -   said heat transfer index is normalized with patient parameters        selected from a group consisting of sex, age, smoking habits,        drinking habits, number of births, height, weight, blood        pressure, diabetes state, medical history, relatives medical        history, patient's previous heat transfer index and any        combination thereof.

It is thus another object of the present invention to disclose thesystem as described above, wherein said active thermomodulation isselected from a group consisting of advecting heat, convecting heat,conducting heat, irradiating and any combination thereof; and saidactive thermomodulation device is selected from a group consisting ofhot fluid inhalation, cold fluid inhalation, hot fluid application,halogen lamp exposure, LED light exposure, xenon lamp exposure, flashlamp exposure, incandescent lamp exposure, IR emission, electromagneticvibration heating, mechanical vibration heating, positioning a heatablesolid, positioning a coolable solid, positioning a heatable patch,positioning a coolable patch, pharmaceutical temperature modification,chemically induced heating, chemically induced cooling and anycombination thereof.

It is thus another object of the present invention to disclose acomputer readable medium (CRM) having instructions which, whenimplemented by one or more computers, causes said one or more computersto:

-   -   collect time-resolved thermal data, at predetermined intervals        over time t, of a plurality of coordinated locations of at least        a portion of said examined tissue by conversion of said signal        from said at least one thermal sensor to time-resolved and        spatially-resolved thermal data; and    -   calculate, according to said time-resolved thermal data, a        thermal transfer index, I, for each of said plurality of        coordinated locations;    -   wherein at least one of the following is being held true:    -   if, for at least one of said plurality of coordinated locations,        said I is greater than a predetermined value I_(irr), determine        tissue at said least one coordinated location as irregular;    -   if, for at least one of said plurality of coordinated locations,        a ratio between said I and a predetermined I-scale is greater        than a predetermined value I_(irr), determine tissue at said        least one coordinated location as irregular;    -   if, for at least two of said plurality of coordinated locations,        a ratio between a first I_(first) of a first coordinated        location and a second I_(second) of a second coordinated        location is greater than a predetermined value I_(irr),        determine tissue at said first coordinated location as        irregular;    -   further wherein said CRM comprises instructions configured to        generate a three or two-dimensional thermal diffusion image of        said at least a portion of said examined tissue.

It is thus another object of the present invention to disclose the CRMas described above, additionally comprising instructions configured tocalculate said I in a manner selected from:

-   -   according to the following formula:        T=a+b*exp(−I*t)    -   where T is temperature at said time t and a and b are constants;    -   according to the following formula:

${\rho C\frac{\partial T}{\partial t}} = {{\nabla\left( {k{\nabla T}} \right)} + q + A_{0} - {b\left( {T - T_{b}} \right)}}$

-   -   where:

$q\left\lbrack \frac{W}{m^{3}} \right\rbrack$is an external heat source;

$A_{0}\left\lbrack \frac{W}{m^{3}} \right\rbrack$is a metabolic heat source;

$b\left\lbrack \frac{W}{m^{3}{{{^\circ}C}.}} \right\rbrack$is a heat loss due to blood perfusion; T_(b) [° C.] is bloodtemperature;

-   -   T [° C.] is temperature;

$\rho\left\lbrack \frac{kg}{m^{3}} \right\rbrack$is density;

$C_{p}\left\lbrack \frac{J}{{kg}\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$is heat capacity; and

$k\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$is thermal conductivity factor;

-   -   from a thermal conductivity coefficient, from a thermal        diffusion coefficient, from a heat capacity, from a density,        from a heat loss due to blood perfusion, from a blood        temperature, from a heat convection index, from a metabolic heat        source and any combination thereof.

It is thus another object of the present invention to disclose the CRMas described above, wherein at least one of the following is held true:

-   -   said at least one irregularity is selected from a group        consisting of a malignant tumor, a precancerous tumor, a benign        tumor, an infection, pneumonia, a necrotic cell, a blood clot        and any combination thereof;    -   said examined tissue is selected from a group consisting of lung        tissue, skin, cervical tissue, ear tissue, nose tissue, throat        tissue, oral tissue, esophageal tissue, stomach tissue,        intestinal tissue, colon tissue, rectal tissue, kidney tissue,        uterine tissue, urinary tract tissue, bladder tissue, prostate        tissue, eye tissue, and any combination thereof; and    -   said time t is selected to be in a range from about 10 ns to        about 10 min.

It is thus another object of the present invention to disclose the CRMas described above, additionally comprising instructions configured toexecute at least one of the following:

-   -   produce at least one heat diffusion image of at least a portion        of said examined tissue prior to said active thermomodulation;    -   identify at least one coordinated location suspected of        containing at least one irregularity by means of image        processing of said at least one heat diffusion image by at least        one object recognition module; and    -   correlate said at least one heat diffusion image and at least        one image from at least one spatial positioner, said at least        one spatial positioner selected from a group consisting of: a        visible light imaging means, a CCD camera, an ultrasound        scanner, a thermal camera, a laser rangefinder and any        combination thereof.

It is thus another object of the present invention to disclose the CRMas described above, additionally comprising instructions configured toprovide a normalization step, at least one of the following being heldtrue:

-   -   said normalizing step comprises normalizing said I to a        predetermined scale, a higher value on said scale indicating a        higher severity of the medical condition associated with said at        least one irregularity;    -   said normalizing step is selected from a group consisting of        correcting to ambient temperature, correcting to ambient        humidity, correcting to ambient electromagnetic radiation and        any combination thereof;    -   said normalizing step is selected from a group consisting of        correcting for ambient temperature, correcting for ambient        humidity, correcting for ambient electromagnetic radiation and        any combination thereof; and    -   said heat transfer index is normalized with patient parameters        selected from a group consisting of sex, age, smoking habits,        drinking habits, number of births, height, weight, blood        pressure, diabetes state, medical history, relatives medical        history, patient's previous heat transfer index and any        combination thereof.

It is thus another object of the present invention to disclose the CRMas described above, wherein said active thermomodulation is selectedfrom a group consisting of advecting heat, convecting heat, conductingheat, irradiating and any combination thereof; and said activethermomodulation device is selected from a group consisting of hot fluidinhalation, cold fluid inhalation, hot fluid application, cold fluidapplication, halogen lamp exposure, LED light exposure, xenon lampexposure, flash lamp exposure, incandescent lamp exposure, IR emission,electromagnetic vibration heating, mechanical vibration heating,positioning a heatable solid, positioning a coolable solid, positioninga heatable patch, positioning a coolable patch, pharmaceuticaltemperature modification, chemically induced heating, chemically inducedcooling and any combination thereof.

It is thus another object of the present invention to disclose a methodfor detecting and diagnosing at least one irregularity in the tissue'scells in an examined tissue, characterized by steps of: activelythermomodulating said examined tissue, or a portion thereof; collectingtime-resolved thermal data, over time t, of a plurality of coordinatedlocations of said examined tissue; calculating according to saidtime-resolved thermal data, a thermal transfer index, I, for each ofsaid plurality of coordinated locations; wherein at least one of thefollowing is being held true: if said I is greater than a predeterminedvalue I_(irr), determining said tissue as irregular; if a ratio betweensaid I and a predetermined I-scale is greater than a predetermined valueI_(irr), determining said tissue as irregular; if a ratio between afirst I_(first) of a first coordinated location and a second I_(second)of a second coordinated location is greater than a predetermined valueI_(irr), determining said tissue as irregular.

It is another object of the present invention to disclose a method fordetecting and diagnosing at least one irregularity in the tissue's cellsin an examined tissue, characterized by steps of: activelythermomodulating said examined tissue, or a portion thereof; collectingtime-resolved thermal data, over time t, of at least one coordinatedlocation of said examined tissue; calculating according to saidtime-resolved thermal data, a thermal transfer index, I, for each ofsaid coordinated locations; wherein said I is defined according to thefollowing formula: T=a+b*exp(−I*t) where a and b are constants and T istemperature.

It is also an object of the present invention to provide theabovementioned method, wherein if said I is greater than a predeterminedvalue I_(irr), determining said tissue as irregular.

It is also an object of the present invention to provide theabovementioned method, wherein if a ratio between said I and apredetermined I-scale is greater than a predetermined value I_(irr),determining said tissue as irregular.

It is also an object of the present invention to provide theabovementioned method, wherein if a ratio between a first I_(first) of afirst coordinated locations and a second I_(second) of a secondcoordinated locations is greater than a predetermined value I_(irr),determining said tissue as irregular.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising steps of constructing avisual presentation of said coordinated locations according to said I oran inferential thereof.

It is also an object of the present invention to provide any of theabovementioned methods, wherein said I is selected from the groupconsisting of an exponential decay constant calculated according to saidtime-resolved thermal data, thermal conductivity coefficient, thermaldiffusion coefficient, heat capacity, density, heat loss due to bloodperfusion, blood temperature, heat convection index, metabolic heatsource and any combination thereof.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising steps of image processingsaid visual presentation by an object recognition module, therebyidentifying coordinated locations suspected of containing at least oneirregularity in the tissue's cells.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising the step of normalizing saidI to a predetermined scale.

It is also an object of the present invention to provide any of theabovementioned methods, wherein said time-resolved thermal data is atemperature measurement taken at predetermined intervals over time.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising normalization steps selectedfrom the group consisting of normalizing said I to ambient temperature,correcting to ambient humidity, correcting to ambient electromagneticradiation and any combination thereof.

It is also an object of the present invention to disclose any of theaforementioned systems, further comprising a spatial positioning meansselected from the group consisting of a visible light imaging means, aCCD camera, an ultrasound scanner, a thermal camera, a laser rangefinderand any combination thereof.

It is also an object of the present invention to provide anon-transitory computer readable medium (CRM) having instructions which,when implemented by one or more computers cause said one or morecomputers to: store time-resolved thermal data of a plurality ofcoordinated locations of an examined tissue, or portion thereof,collected over time t; calculate according to said time-resolved thermaldata, a thermal transfer index, I, for each of said plurality ofcoordinated locations; wherein at least one of the following is beingheld true: if said I is greater than a predetermined value I_(irr),determining said tissue as irregular; if a ratio between said I and apredetermined I-scale is greater than a predetermined value I_(irr),determining said tissue as irregular; if a ratio between a firstI_(first) of a first coordinated location and a second I_(second) of asecond coordinated location is greater than a predetermined valueI_(irr), determining said tissue as irregular.

It is yet another object of the present invention to provide anon-transitory computer readable medium (CRM) having instructions which,when implemented by one or more computers cause said one or morecomputers to: store time-resolved thermal data of a plurality ofcoordinated locations of an examined tissue, or portion thereof,collected over time t; calculate according to said time-resolved thermaldata, a thermal transfer index, I, for each of said plurality ofcoordinated locations; wherein said I is defined according to thefollowing formula: T=a+b*exp(−I*t) where a and b are constants and T istemperature.

It is thus one object of the present invention to disclose a method fordetecting and diagnosing at least one irregularity in the tissue's cellsin an examined tissue, characterized by steps of: activelythermomodulating said examined tissue, or a portion thereof; collectingtime-resolved thermal data, over time t, of a plurality of coordinatedlocations of said examined tissue; calculating according to saidtime-resolved thermal data, a thermal transfer index, I, for each ofsaid plurality of coordinated locations; wherein at least one of thefollowing is being held true: if said I is greater than a predeterminedvalue I_(irr), determining said tissue as irregular; if a ratio betweensaid I and a predetermined I-scale is greater than a predetermined valueI_(irr), determining said tissue as irregular; if a ratio between afirst I_(first) of a first coordinated location and a second I_(second)of a second coordinated location is greater than a predetermined valueI_(irr), determining said tissue as irregular.

It is another object of the present invention to disclose method fordetecting and diagnosing at least one irregularity in the tissue's cellsin an examined tissue, characterized by steps of: activelythermomodulating said examined tissue, or a portion thereof; collectingtime-resolved thermal data, over time t, of at least one coordinatedlocation of said examined tissue; calculating according to saidtime-resolved thermal data, a thermal transfer index, I, for each ofsaid coordinated locations; wherein said I is defined according to thefollowing formula: T=a+b*exp(−I*t) where T is the temperature and a andb are constants.

It is also an object of the present invention to provide theabovementioned method, wherein if said I is greater than a predeterminedvalue I_(irr), determining said tissue as irregular.

It is also an object of the present invention to provide theabovementioned method, wherein if a ratio between said I and apredetermined I-scale is greater than a predetermined value I_(irr),determining said tissue as irregular.

It is also an object of the present invention to provide theabovementioned method, wherein if a ratio between a first I_(first) of afirst coordinated locations and a second I_(second) of a secondcoordinated locations is greater than a predetermined value I_(irr),determining said tissue as irregular.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising steps of constructing avisual presentation of said coordinated locations according to said I oran inferential thereof.

It is also an object of the present invention to provide any of theabovementioned methods, wherein said I is selected from the groupconsisting of an exponential decay constant calculated according to saidtime-resolved thermal data, thermal conductivity coefficient, thermaldiffusion coefficient, heat capacity, density, heat loss due to bloodperfusion, blood temperature, heat convection index, metabolic heatsource and any combination thereof.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising steps of image processingsaid visual presentation by an object recognition module, therebyidentifying coordinated locations suspected of containing at least oneirregularity in the tissue's cells.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising the step of normalizing saidI to a predetermined scale.

It is also an object of the present invention to provide any of theabovementioned methods, wherein said time-resolved thermal data is atemperature measurement taken at predetermined intervals over time.

It is also an object of the present invention to provide any of theabovementioned methods, further comprising normalization steps selectedfrom the group consisting of normalizing said I to ambient temperature,correcting to ambient humidity, correcting to ambient electromagneticradiation and any combination thereof.

It is also an object of the present invention to disclose any of theaforementioned systems, further comprising a spatial positioning meansselected from the group consisting of a visible light imaging means, aCCD camera, an ultrasound scanner, a thermal camera, a laser rangefinderand any combination thereof.

It is also an object of the present invention to provide anon-transitory computer readable medium (CRM) having instructions which,when implemented by one or more computers cause said one or morecomputers to: store time-resolved thermal data of a plurality ofcoordinated locations of an examined tissue, or portion thereof,collected over time t; calculate according to said time-resolved thermaldata, a thermal transfer index, I, for each of said plurality ofcoordinated locations; wherein at least one of the following is beingheld true: if said I is greater than a predetermined value I_(irr),determining said tissue as irregular; if a ratio between said I and apredetermined I-scale is greater than a predetermined value I_(irr),determining said tissue as irregular; if a ratio between a firstI_(first) of a first coordinated location and a second I_(second) of asecond coordinated location is greater than a predetermined valueI_(irr), determining said tissue as irregular.

It is yet another object of the present invention to provide anon-transitory computer readable medium (CRM) having instructions which,when implemented by one or more computers cause said one or morecomputers to: store time-resolved thermal data of a plurality ofcoordinated locations of an examined tissue, or portion thereof,collected over time t; calculate according to said time-resolved thermaldata, a thermal transfer index, I, for each of said plurality ofcoordinated locations; wherein said I is defined according to thefollowing formula: T=a+b*exp(−I*t) where T is the temperature and a andb are constants.

It is another object of the present invention to provide a method fordetecting and diagnosing at least one irregularity in the tissue's cellsin an examined tissue, characterized by the steps of: applyingthermomodulating means to at least a portion of the examined tissue;collecting at least one thermal data of at least a portion of the tissueover time; and calculating at least one heat transfer index of thethermal data over time; thereby detecting and diagnosing at least oneirregularity in the tissue's cells according to the at least one heattransfer index; wherein the heat transfer index is calculated accordingto a derivative of the thermal data over time.

It is another object of the present invention to provide the abovementioned method, further comprising the step of selecting thederivative to be from the group consisting of first derivative, secondderivative, third derivative and any combination thereof.

It is another object of the present invention to provide the abovementioned method, further comprising the step of normalizing the heattransfer index to a predetermined scale.

It is another object of the present invention to provide the abovementioned method, wherein the scale is a numerical scale between 1 and10, further wherein a higher value indicates a higher severity of themedical condition of the at least one irregularity in the tissue'scells.

It is another object of the present invention to provide the abovementioned method, further comprising the step of correlating the heattransfer index with associated at least one irregularity in the tissue'scells selected from the group consisting of malignant tumors,precancerous tumors, benign tumors, infections, pneumonia, necroticcells and any combination thereof.

It is another object of the present invention to provide the abovementioned method, further comprising the step of collecting the thermaldata using a sensor selected from the group consisting of an IR sensor,a mercury-in-glass thermometer, pill thermometer, liquid crystalthermometer, thermocouple, thermistor, resistance temperature detector,silicon bandgap temperature sensor and any combination thereof.

It is another object of the present invention to provide the abovementioned method, wherein the at least one thermal data is a temperaturemeasurement of the at least a portion of the tissue over time.

It is another object of the present invention to provide the abovementioned method, further comprising the steps of: collecting thermalimage data of at least a portion of the tissue over time; calculatingheat transfer index of the thermal image data over time; constructing aheat transfer map comprising, optionally spatial (i.e.three-dimensional), locations of the heat transfer index over time; andidentifying a designated location in the heat diffusion image havingdistinctive heat transfer index from surrounding spatial locations.

It is another object of the present invention to provide the abovementioned method, further comprising the step of producing a heatdiffusion image of the at least a portion of the tissue prior to theapplying thermomodulating means to the tissue.

It is another object of the present invention to provide the abovementioned method, further comprising the step of deeming a designatedspatial location of the heat transfer map suspect of at least oneirregularity in the tissue's cells if the designated spatial locationhas the heat transfer index falling within a predetermined heat transferindex range.

It is another object of the present invention to provide the abovementioned method, wherein the spatial location is selected from thegroup consisting of one pixel, a plurality of pixels, a sub-pixel andany combination thereof.

It is another object of the present invention to provide the abovementioned method, further comprising the step of comparing the heattransfer map to a spatial image of the examined tissue's area.

It is another object of the present invention to provide the abovementioned method, further comprising a step of selecting said time t tobe in a range from about 10 ns to about 10 min.

It is another object of the present invention to provide the abovementioned method, wherein during the step of applying thermomodulatingmeans to the tissue, the method further comprises the steps of:collecting thermal data of at least a portion of the tissue over time,for tracking the thermoregulation; and calculating heat transfer indexof the thermal data in real-time.

It is another object of the present invention to provide the abovementioned method, further comprising the step of constructing a heattransfer map comprising spatial locations of the real-time heat transferindex.

It is another object of the present invention to provide the abovementioned method, further comprising normalization steps selected fromthe group consisting of correcting to ambient temperature, correcting toambient humidity, correcting to ambient electromagnetic radiation andany combination thereof.

It is another object of the present invention to provide the abovementioned method, further comprising the steps of providing access to acervix area by a mechanical speculum; applying the heating and/orcooling to the cervix area; and correlating the heat transfer index withCervical Intraepithelial Neoplasia (CIN).

It is another object of the present invention to provide the abovementioned method, further comprising the step of deriving the examinedtissue from a mammal selected from the group consisting of human,monkey, rodent, sheep, goat, cow, horse and swine.

It is another object of the present invention to provide the abovementioned method, wherein the examined tissue is selected from the groupconsisting of lungs, skin, cervix, ear, nose, throat, oral cavities,esophagus, stomach, intestine, colon, rectum, kidney, uterus, urinarytract, bladder, prostate, eyes, and any part of the human body.

It is another object of the present invention to provide the abovementioned method, further comprising the step of selecting thethermomodulating means to operate in a manner selected from the groupconsisting of advection, convection, conduction, radiation and anycombination thereof.

It is another object of the present invention to provide the abovementioned method, wherein the thermomodulating means is selected fromthe group consisting of heating means, cooling means and any combinationthereof.

It is another object of the present invention to provide the abovementioned method, further comprising the step of applying the heatingand/or cooling means by a method selected from the group consisting ofhot and/or cold fluid inhalation, hot and/or cold fluid application,halogen lamp exposure, LED light exposure, xenon lamp exposure, flashlamp exposure, incandescent lamp exposure, IR emission, radiation,electromagnetic and/or mechanical vibration heating, hot and/or coldsolid positioning, hot and/or cold patch positioning, pharmaceuticalheat modification, chemically induced heating and/or cooling and anycombination thereof.

It is another object of the present invention to provide the abovementioned method, wherein the step of collecting thermal data of atleast a portion of the tissue over time is conducted by a thermal sensorpositioned in a position selected from the group consisting of mountedoutside the body, inserted to the body in an invasive procedure,inserted to the body in a semi-invasive procedure and any combinationthereof.

It is another object of the present invention to provide the abovementioned method, further comprising the step of calculating the heattransfer index according to the thermal sensor resolution and samplingrate.

It is another object of the present invention to provide the abovementioned method, wherein the examined tissue is a biopsy sampling of asuspected tissue area.

It is another object of the present invention to provide the abovementioned method, further comprising the steps of applying the method toa second examined tissue being a biopsy sampling of a healthy tissuearea, and obtained heat transfer index is compared between the suspectedtissue area and the healthy tissue area.

It is another object of the present invention to provide the abovementioned method, further comprising the steps of using the heattransfer index for at least one of the following: detecting and mappingtumor boundaries for tumor removal operations; and determining medicalseverity and/or malignancy status of the at least one irregularity inthe tissue's cells.

It is another object of the present invention to provide the abovementioned method, further comprising the step of normalizing the heattransfer index with patient parameters selected from the groupconsisting of sex, age, smoking habits, drinking habits, number ofbirths, height, weight, blood pressure, diabetes state, medical history,relatives medical history, patient's previous heat transfer index andany combination thereof.

It is another object of the present invention to provide the abovementioned method, further comprising the steps of: applyingthermomodulating means to a second tissue; collecting second thermaldata of at least a portion of the second tissue over time; calculating abaseline heat transfer index of the second heat diffusion image dataover time; comparing the baseline heat transfer index to the heattransfer index of the examined tissue; and detecting and diagnosing atleast one irregularity in the tissue's cells according to a differencebetween the baseline heat transfer index of the second tissue to theheat transfer index of the examined tissue.

It is another object of the present invention to provide the abovementioned method, wherein at least one of the following is being heldtrue: the second tissue is healthy; the second tissue comprises at leastone irregularity in the tissue's cells;

It is another object of the present invention to provide the abovementioned method, further comprising the step of obtaining the baselineheat transfer index from a database comprising heat transfer indexobtained from at least one second tissue deriving from an examinedindividual and/or from at least one second examined individuals.

It is another object of the present invention to provide the abovementioned method, further comprising the step of deriving a ratiobetween the heat transfer index of the examined tissue and a second heattransfer index of a second examined tissue, and comparing the ratio toat least one second ratio between a third heat transfer index of a thirdexamined tissue, and a fourth heat transfer index of a fourth examinedtissue.

It is another object of the present invention to provide the abovementioned method, wherein the second examined tissue is tissuesurrounding the first tissue.

It is another object of the present invention to provide the abovementioned method, further comprising the step of obtaining the thirddistinctive heat transfer index and fourth heat transfer index from adatabase comprising heat transfer index obtained from a plurality oftissues deriving from an examined individual and/or a plurality ofexamined individuals.

It is another object of the present invention to provide the abovementioned method, further comprising the step of storing the baselineheat transfer index in a storing means selected from the groupconsisting of a computer readable medium, a server, a cloud-like serverand any combination thereof.

It is another object of the present invention to provide the abovementioned method, further comprising the steps of applying thethermomodulating means according to a manner selected from the groupconsisting of according to a pre-determined protocol, in a continuousmanner, in a pulse manner and any combination thereof.

It is also an object of the present invention to disclose a system fordetecting and diagnosing at least one irregularity in the tissue's cellsin an examined tissue, comprising: a thermomodulating means for applyingheating and/or cooling to at least a portion of the examined tissue; athermal sensor for collecting at least one thermal data of at least aportion of the examined tissue over time; and a processor adapted toread a computer readable medium with instructions for calculating atleast one heat transfer index of the thermal data over time; therebydetecting and diagnosing at least one irregularity in the tissue's cellsaccording to the at least one heat transfer index; wherein the heattransfer index is calculated according to a derivative of the thermaldata over time.

It is still an object of the present invention to disclose theaforementioned system, wherein the derivative is selected from the groupconsisting of first derivative, second derivative, third derivative andany combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the processor is further adapted tonormalize the heat transfer index to a predetermined scale.

It is still an object of the present invention to disclose theaforementioned system, wherein the scale is a numerical scale between 1and 10, further wherein a higher value indicates a higher severity ofthe medical condition of the at least one irregularity in the tissue'scells.

It is still an object of the present invention to disclose theaforementioned system, wherein the processor is further adapted to reada computer readable medium with instructions for correlating the heattransfer index with associated at least one irregularity in the tissue'scells selected from the group consisting of malignant tumors,precancerous tumors, benign tumors, infections, pneumonia, necroticcells and any combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the thermal sensor is selected from thegroup consisting of an IR sensor, a mercury-in-glass thermometer, pillthermometer, liquid crystal thermometer, thermocouple, thermistor,resistance temperature detector, silicon bandgap temperature sensor andany combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the at least one thermal data is atemperature measurement of the at least a portion of the tissue overtime.

It is still an object of the present invention to disclose theaforementioned system, further comprising a step of selecting said timet to be in a range from about 10 ns to about 10 min.

It is still an object of the present invention to disclose theaforementioned system, wherein the processor is further adapted to reada computer readable medium with instructions for: calculating heattransfer index of thermal image data obtained over time; constructing aheat transfer map comprising, optionally spatial, locations of the heattransfer index over time, thereby generating a thermal diffusivityimage; and identifying a designated spatial location in the thermaldiffusivity image having a distinctive heat transfer index fromsurrounding spatial locations.

It is still an object of the present invention to disclose theaforementioned system, wherein, if a designated spatial location of theheat transfer map has the heat transfer index falling within apredetermined slope, the designated spatial location is deemed suspectof at least one irregularity in the tissue's cells.

It is still an object of the present invention to disclose theaforementioned system, wherein the spatial location is selected from thegroup consisting of one pixel, a plurality of pixels, a sub-pixel andany combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the thermal sensor is adapted to collectthermal data of at least a portion of the tissue over time, while thethermomodulating means is applied, thereby enabling the processor tocalculate the heat transfer index in real-time.

It is still an object of the present invention to disclose theaforementioned system, further comprising at least one sensor selectedfrom the group consisting of a thermometer, a hygrometer, aphotodetector and any combination thereof.

It is still an object of the present invention to disclose theaforementioned system, further comprising a spatial positioning meansselected from the group consisting of a visible light imaging means, aCCD camera, an ultrasound scanner, a thermal camera, a laser rangefinderand any combination thereof.

It is still an object of the present invention to disclose theaforementioned system, further comprising a mechanical speculum.

It is still an object of the present invention to disclose theaforementioned system, wherein the distinctive heat transfer index iscorrelated with Cervical Intraepithelial Neoplasia (CIN).

It is still an object of the present invention to disclose theaforementioned system, wherein the examined tissue is derived from amammal selected from the group consisting of human, monkey, rodent,sheep, goat, cow, horse and swine.

It is still an object of the present invention to disclose theaforementioned system, wherein the examined tissue is selected from thegroup consisting of lungs, skin, cervix, ear, nose, throat, oralcavities, esophagus, stomach, intestine, colon, rectum, kidney, uterus,urinary tract, bladder, prostate, eyes, and any part of the human body.

It is still an object of the present invention to disclose theaforementioned system, further comprising a display means for presentinga graphical representation of a feature selected from the groupconsisting of a user interface, the heat transfer map, the heat transferindex analysis, the marking of at least one irregularity in the tissue'scells, border lines of the marking of at least one irregularity in thetissue's cells, a visual image of the examined tissue's area, thethermal data, the thermal image data, the heat diffusion image and anycombination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the display is adapted to further displaydata relating to patient parameters selected from the group consistingof sex, age, smoking habits, drinking habits, number of births, height,weight, blood pressure, diabetes state, medical history, relatives'medical history, patient's previous heat transfer index analysis and anycombination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the thermomodulating means are adapted toprovide and/or draw heat in a manner selected from the group consistingof advection, convection, conduction, radiation and any combinationthereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the thermomodulating means are adapted toheat the at least a portion of the examined tissue, or cool the at leasta portion of the examined tissue, or both.

It is still an object of the present invention to disclose theaforementioned system, wherein the thermomodulating means are selectedfrom the group consisting of hot and/or cold fluid inhalation, hotand/or cold fluid application, halogen lamp exposure, LED lightexposure, xenon lamp exposure, flash lamp exposure, incandescent lampexposure, IR emission, radiation, electromagnetic and/or mechanicalvibration heating, hot and/or cold solid positioning, hot and/or coldpatch positioning, pharmaceutical heat modification, chemically inducedheating and/or cooling and any combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the thermal sensor position is selectedfrom the group consisting of mounted outside the body, inserted to thebody in an invasive procedure, inserted to the body in a semi-invasiveprocedure and any combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the heat transfer index is calculatedaccording to the thermal sensor's resolution, sampling rate and camerasensitivity.

It is still an object of the present invention to disclose theaforementioned system, wherein the examined tissue is a biopsy samplingof a tissue area suspected of having at least one irregularity in thetissue's cells.

It is still an object of the present invention to disclose theaforementioned system, wherein a second examined tissue is a biopsysampling of a healthy tissue area, and obtained heat transfer index iscompared between the suspected tissue area and the healthy tissue area.

It is still an object of the present invention to disclose theaforementioned system, wherein the heat transfer index is used for atleast one of the following: detecting and mapping tumor boundaries fortumor removal operations; and determining medical severity and/ormalignancy status of the at least one irregularity in the tissue'scells.

It is still an object of the present invention to disclose theaforementioned system, further comprising a database containing at leastone heat transfer index of at least one second tissue, and furtherwherein the processor is adapted to: compare between the at least onebaseline heat transfer index of at least one second examined tissue andthe at least one heat transfer index of at least one examined tissue,and detect and diagnose at least one irregularity in the tissue's cellsaccording to a difference between the baseline heat transfer index ofthe second tissue to the heat transfer index of the examined tissue.

It is still an object of the present invention to disclose theaforementioned system, wherein the second examined tissue is selectedfrom the group consisting of a healthy tissue, a tissue containing atleast one irregularity in the tissue's cells and any combinationthereof.

It is still an object of the present invention to disclose theaforementioned system, further comprising a storing means for storingthe database, selected from the group consisting of a computer readablemedium, a server, a cloud-like server and any combination thereof.

It is still an object of the present invention to disclose theaforementioned system, wherein the processor is in operativecommunication with the storing means, optionally wirelessly.

It is also an object of the present invention to provide a computerreadable medium (CRM), or electronics component, having instructionswhich, when implemented by one or more computers cause the one or morecomputers to: process thermal data derived from a thermal sensorcollected over time; calculate at least one heat transfer index of thethermal data over time; wherein the heat transfer index is calculatedaccording to a derivative of the thermal data over time.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, wherein the derivative isselected from the group consisting of first derivative, secondderivative, third derivative and any combination thereof.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, further wherein theinstructions which, when implemented by one or more computers cause theone or more computers to normalize the heat transfer index to apredetermined scale.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, wherein the scale is anumerical scale between 1 and 10, further wherein a higher valueindicates a higher severity of the medical condition of the at least oneirregularity in the tissue's cells.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, further wherein theinstructions which, when implemented by one or more computers cause theone or more computers to correlate the distinctive heat transfer indexwith associated at least one irregularity in the tissue's cells; therebydetecting and diagnosing at least one irregularity in the tissue'scells.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, further wherein theinstructions which, when implemented by one or more computers cause theone or more computers to correlate distinctive the heat transfer indexwith associated at least one irregularity in the tissue's cells selectedfrom the group consisting of malignant tumors, precancerous tumors,benign tumors, infections, pneumonia, necrotic cells and any combinationthereof.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, further wherein theinstructions which, when implemented by one or more computers cause theone or more computers to: construct a heat transfer map comprising,optionally spatial, locations of the heat transfer index over time; andpresent on a display unit a designated spatial location in the heattransfer map having distinctive heat transfer index from surroundingspatial locations.

It is still an object of the present invention to disclose theaforementioned CRM or electronics component, wherein the instructionswhich, when implemented by one or more computers cause the one or morecomputers to present on a display unit a designated spatial location inthe heat transfer map having distinctive heat transfer index fromsurrounding spatial locations, further wherein the spatial location isselected from the group consisting of one pixel, a plurality of pixels,a sub-pixel and any combination thereof.

BRIEF DESCRIPTION OF THE FIGURES

The novel features believed to be characteristics of the invention areset forth in the appended claims. The invention itself, however, as wellas the preferred mode of use, further objects and advantages thereof,will best be understood by reference to the following detaileddescription of illustrative embodiment when read in conjunction with theaccompanying drawings, wherein:

FIG. 1 presents a top level scheme of the method disclosed by thepresent invention;

FIG. 2 schematically presents high level overview of a preferredembodiment of the system disclosed by the present invention;

FIG. 3 schematically presents a high level overview of a preferredembodiment of the method disclosed by the present invention;

FIG. 4 presents the cell types examined under the present invention andtheir index numbers;

FIG. 5A-B illustrates a first experimental setup using six cell typesfor examination. FIG. 5A illustrates the cell types and theirexperimental configuration, while FIG. 5B illustrates a visualdemonstration of the heat transfer map of the six cell types illustratedin FIG. 5A;

FIG. 6 graphically illustrates temperature decay profiles of theexamined cell populations presented in FIGS. 5A and B;

FIG. 7 graphically illustrates the first derivative of the datapresented in FIG. 6;

FIGS. 8A-B show an example of a graphical representation of data asobtained from a cured swine meat, wherein FIG. 8A exemplifies a spatialpositioning means, i.e. a camera, and FIG. 8B represents the graphicalpresentation of the thermal data collected by a thermal sensor;

FIG. 9 graphically illustrates temperature decay profiles of two sets oftissue cultures as presented in FIG. 5;

FIG. 10 illustrates a CT image of a horizontal slice through a normalhuman chest at the level of the heart, with overlay lines to show theedges of a simplified geometry for a simulation;

FIG. 11 illustrates the simplified geometry used for simulation,including a simplified heart, simplified skin, muscle and bone, and anexemplary growth;

FIG. 12 illustrates a simulation of a steady-state temperature map ofthe slice of the chest;

FIG. 13 illustrates a simulation of a temperature map of the slice ofthe chest after inhalation of a hot gas;

FIG. 14 illustrates a simulation of the change in the temperatureprofile as the chest cools back to its steady state temperature profileafter heating; and

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following description is provided, alongside all chapters of thepresent invention, so that to enable any person skilled in the art tomake use of the invention and sets forth the best modes contemplated bythe inventor of carrying out this invention. Various modifications,however, will remain apparent to those skilled in the art, since thegeneric principles of the present invention have been definedspecifically to provide a method for detection and diagnosis of at leastone irregularity in the tissue's cells in a healthy tissue.

The term “at least one irregularity in the tissue's cells” refershereinafter to malignant tumors, precancerous tumors, benign tumors,neoplasms, infections, pneumonia infected cells, necrotic cells,infected cells, blood clots and any other cell type exhibitingdistinctive thermal transfer properties from healthy standard tissue.

The term “camera sensitivity” refers hereinafter to the capacity to havethe signal stand out from the surrounding noise, i.e. thesignal-to-noise ratio acquired by the camera, and in the case of athermal sensor, this translates to the capacity to detect minutetemperature differences.

The term “radiation” refers hereinafter to the use of any visible ornon-visible radiation which has the capacity to elevate the temperatureof the target tissue, such as emitted by, in a non-limiting manner,halogen lamp, incandescent lamp, IR emission, and pertaining to any suchelectromagnetic wave and non-ionizing radiation.

The term “hot” or “heating” refers hereinafter to a temperature higherthan the examined tissue, or an object having a temperature higher thanthe examined tissue.

The term “cold” or “cooling” refers hereinafter to a temperature lowerthan 37° C., or an object having a temperature lower than 37° C.

The term “fluid” refers hereinafter to a liquid or a gas, which may behot or cold, and may refer to in a non-limiting example to atmosphericair, oxygen, nitrogen, helium, hydrogen, carbon dioxide, steam, water oroil.

The term “spatial positioner” refers hereinafter to any imaging deviceproviding information with regards to the physical position of theexamined tissue, and may include visible-light imaging means, such as aCCD camera, a laser rangefinder, an ultrasound scanner and so forth,resulting in a spatial image of the examined tissue's area. Spatialpositioning means may give out results in a one dimensional output, twodimensional or three dimensional output.

The term “thermal data” refers hereinafter to any numerical orimage-like data depicting the temperature of at least a portion of anexamined tissue.

The term “thermal image data” refers hereinafter to a visualrepresentation of thermal data in the form of a digital image.

The term “heat transfer map” refers hereinafter to thermal image datadepicting the change in temperature of at least a portion of an examinedtissue over time.

The term “heat diffusion image” refers hereinafter to an image depictingthe thermal diffusivity of at least a portion of an examined tissue overtime.

The term “heat transfer index” refers hereinafter to the rate of heattransfer exhibited by at least a portion of an examined tissue afterbeing exposed to active thermoregulation.

The term “tissue” refers hereinafter to any of a tissue culture, a cellline, a biopsy sampling, an in situ tissue (i.e. in the examined animal)and the like.

The term “thermomodulating means” refers hereinafter to any means ormethod for heating or cooling a tissue.

The present invention exploits active thermography to identify minutevariations between healthy tissues as compared to tissues undergoingcancerous/precancerous stages, or any other irregularity in at least onecell of the examined tissue. Active thermography is the induction of aheat flow by energetically exciting a test object. The heat flow isinfluenced by interior material layers and defects. Theseinhomogeneities can be captured on the surface by high-precision thermalsensors. The inventors of the present invention have discovered thateven a minor differentiation of tissue cells, such as in precancerousconditions, results in biomechanical-thermal differences which lead todifferences in heat flow, and therefore to a distinctive thermaldiffusivity and heat transfer.

Reference is now made to FIG. 1 illustrating a top level overview of thecore technological features of the present invention's system 100.Thermal excitation source 101, or thermomodulating means, is first usedon an examined tissue. The thermal excitation may be throughtransferring heat to the tissue by any energy inducing device or throughdrawing heat from the tissue through exposure to cold objects, or by anypharmaceutical administration altering body temperature, or by anychemical reaction configured to induce temperature alterations in anypart of the body. After such thermal excitation, heat transfer isinduced throughout the tissue. The heat transfer is dependent on thethermal diffusivity properties of the tissue, such that healthy tissuehas certain thermal diffusivity properties and tissues having at leastone irregularity in the tissue's cells exhibit distinctive thermaldiffusivity properties. Heat transfer may be the result of advection,convection, conduction, radiation and may be carried out by any deviceor means such as, in a non-limiting example, hot and/or cold fluidinhalation, hot and/or cold fluid application, halogen lamp exposure,LED light exposure, xenon lamp exposure, flash lamp exposure,incandescent lamp exposure, IR emission, radiation, electromagneticand/or mechanical vibration heating, hot and/or cold solid positioning,hot and/or cold patch positioning, pharmaceutical heat modification,chemically induced heating and/or cooling and any combination thereof.

In various embodiments of the present invention, the examined tissue maybe at least a section of a tissue in an examined individual. Suchindividual may be any mammal, such as in a non-limiting example, human,monkey, rodent, sheep, goat, cow, horse and swine, and may be derivedfrom any body part, including in a non-limiting example, lungs, skin,cervix, ear, nose, throat, oral cavities, esophagus, stomach, intestine,colon, rectum, kidney, uterus, urinary tract, bladder, prostate andeyes. Preferably, the examined body part is of a kind that is accessibleto thermal excitation and thermal sensing.

In other embodiments of the present invention, the examined tissue maybe an in vitro examined biopsy sample taken from at least a section of atissue of an examined individual. The biopsy sample may be healthytissue or tissue suspected of having at least one irregularity in thetissue's cells. And yet in other embodiments, the examined tissue may bean extracted cell line or cell culture grown on a dish.

In preferred embodiments the examined tissue is human cervix tissueexamined in situ i.e. in the patient himself, and the resultantidentified at least one irregularity in the tissue's cells are CervicalIntraepithelial Neoplasia (CIN). However, at least one irregularity inthe tissue's cells may also refer to any cancerous or precanceroustissues found in any other part of the examined body.

The heat transfer is monitored with thermal sensor 102, which ispreferred to be an IR camera or IR sensor, but may be any sensor whichcould provide thermal data, which is preferably temperature values.Other sensors which may be used are an ultrasound temperature sensor, amercury-in-glass thermometer, a pill thermometer, a liquid crystalthermometer, a thermocouple, a thermistor, a resistance temperaturedetector, a silicon bandgap temperature sensor and any combinationthereof. In some embodiments, the thermal sensor produces thermal datawhich consists of a series of time-resolved temperature measurements. Inother embodiments, thermal sensor 102 can produce a plurality oftime-resolved thermal image data, or thermal digital images, preferablyover a time interval in a range from about 10 ns to about 10 min.Thermal sensor 102 may be mounted outside the body or inserted into thebody in an invasive procedure, or in a semi-invasive procedure.

Thermal data, or thermal image data is then transferred to a processorcomprising thermal analysis software 103. This processor is found inoperative communication with thermal sensor 102, optionally throughwireless communication.

In some embodiments, the thermal analysis software 103 can containinstructions for calculating the heat transfer index, i.e. the rate inwhich the heat transferred through the examined tissue, according to thethermal data, or thermal image data taken over time. These calculationsinclude deriving the derivative of the change in the thermal datadetected over time. The derivative may be a first derivative, a secondderivative or a third derivative of the thermal data, or thermal imagedata (through spatial location intensity derivation), and anycombination thereof. A plurality of such heat transfer indexes may bethen used to construct a heat transfer map exhibiting these temporalheat transfer indexes through spatial locations, which may be at asingle pixel resolution, a plurality of pixel resolution or sub-pixelresolution, which is less than one pixel, i.e. super-resolution.Optionally, binning is used to illustrate the heat transfer index, i.e.through spatial locations which comprise a plurality of pixels. At leastone irregularity in the tissue's cells are identified by identifying adesignated spatial location having a distinctive heat transfer indexfrom its surrounding spatial locations. At least one irregularity in thetissue's cells may also be detected or diagnosed through suspected heattransfer index, or heat transfer index which is found within a knownheat transfer range to be suspected of at least one irregularity in thetissue's cells.

In some embodiments, thermal analysis software 103 calculates the heattransfer index through an algorithm comprising first measuring theintensity of each of the spatial locations, followed by determining afirst derivative of the measured intensity over time, and finallydetermining the heat transfer index according to the first derivative.In an embodiment of the present invention, a second or third derivativeof the intensity over time may be used to calculate the heat transferindex. In various embodiments the heat transfer index is calculated inaccordance with the thermal sensor's resolution, sampling rate andsensitivity.

In some embodiments, the thermal analysis software 103 containsinstructions for calculating the thermal rate index, which may be insome embodiments the thermal transfer rate constant, i.e. the typicaltime it takes for the active thermo-modulation to decay or recover in aspecific tissue region, for each of the coordinated locations. Eachtissue type, depending on its unique composition and metabolic activity,exhibits a different rate constant. This means that coordinatedlocations comprising portions of the tissue having at least oneirregularity in the tissue's cells, will exhibit a thermal rate constantwhich is different from the surrounding, other healthy portions of thetissue. It is thus disclosed by the present invention that determiningthe rate in which active thermal modulation equilibrates over time invarious tissues reveals nuances and differences between such tissues,which may not be detected using a different stimulation, detection oranalysis. A plurality of such thermal rate indexes may then be used toconstruct a visual presentation, in the form of a map, exhibiting thesetemporal thermal rate differences according to the coordinatedlocations, which may be at a single pixel resolution, a plurality ofpixel resolution or sub-pixel resolution, which is less than one pixel,i.e. super-resolution, or may comprise a single cell resolution, or aplurality of cells. Optionally, binning is used to illustrate thethermal rate constants, i.e. through averaging spatial locations whichcomprise a plurality of pixels. At least one irregularity in thetissue's cells are diagnosed by identifying a designated spatial, i.e.coordinated, location having a distinctive thermal rate index from itssurrounding spatial locations. At least one irregularity in the tissue'scells may also be detected or diagnosed through thermal rate constantswhich are found within a known range suspected of relating to at leastone irregularity in the tissue's cells.

The thermal transfer index, I, is used to obtain a threshold value whichwill be correlated with a predetermined value I_(irr), establishing adiagnosis. The index I may be directly correlated to the value I_(irr),or it may be normalized by a scale value I_(scale). In variousembodiments, I is calculated for at least two distinct coordinatedlocations, and then a first calculated I_(first) is normalized to asecond calculated I_(second), and the result is then compared toI_(irr).

In various other embodiments, the thermal transfer index is definedaccording to the formula of T=a+b*exp(−I*t), where a and b areconstants, T is the temperature and t is the time over which the thermaldata was collected.

In various embodiments of the present invention, the thermal rate indexis not used directly in constructing the heat map, or visualpresentation, but an inferential thereof is used. Such inferential valueis derived from the thermal rate index in some kind of a mathematicalmanipulation and may lead to important metabolic parameters such asthermal conductivity coefficient, thermal diffusion coefficient, heatcapacity, density, heat loss due to blood perfusion, blood temperature,heat convection index, metabolic heat source and any combinationthereof.

In order to construct the visual presentation, or heat map, the thermalrate constant, or an inferential thereof, is normalized to apredetermined numerical scale, which is pre-associated with color, orpixel intensity, or both. In some embodiments, the scale is a numericalscale of between 1 and 10, wherein 1 could represent healthy cells or 1could represent the most severe case of at least one irregularity in thetissue's cells. Such a scale should provide the practitioner using thesystem and method of the present invention with a tool for outlining theboundary of the malignant tissue, by means of the map, and also forestimating the severity of the condition. Use of the tool can assist apractitioner to determine a more optimal treatment of the irregularity.

In preferred embodiments, thermal analysis software 103 calculates thethermal rate constant through an algorithm comprising first measuringthe intensity of each of the spatial locations, and following theintensity modification over time, and finally extracting the thermalrate constant, usually by finding the exponential decay constant of themeasured heat decay profile. In various embodiments of the presentinvention, the thermal rate constant may be a heat decay rate detectedafter heating, or it may be a heat recovery rate detected after cooling.In various embodiments the thermal rate constant is calculated inaccordance with the thermal sensor's resolution, sampling rate andsensitivity.

In some embodiments, thermal sensor 102 is operated during the heatingand/or cooling applied by thermal excitation source 101, andconsequently, thermal analysis software 103 is configured to calculatethe thermal diffusion through the examined tissue, as a consequence ofthe application of thermal sensor 101, in real-time.

In various embodiments, the heat transfer index is normalized againstpersonal patient parameters such as, in a non-limiting example, sex,age, smoking habits, drinking habits, number of births, height, weight,blood pressure, diabetes state, medical history, relative's medicalhistory, the patient's own previous heat transfer index analysis and anycombination thereof.

In an embodiment of the present invention, the heat transfer map'semerging markings of distinctive heat transfer indexes is used fordetecting and mapping the at least one irregularity in the tissue'scells' borders and for surgical removal of the markings findings.

Results of thermal analysis software 103 are then displayed on displaymeans 104 comprising a user interface. The display means may be amonitor which is part of the system, or of a personal computer or thescreen of any other electronic device such as a personal tablet,smartphone, smart TV and the like. The electronic device may comprisethe thermal analysis software 103 in itself or may be in operativecommunication with the processor comprising thermal analysis software103, wirelessly or through wire communication.

At least one irregularity in the tissue's cells may be recognized bycorrelating the emerging heat transfer index with associated at leastone irregularity in the tissue's cells, which may be selected from agroup consisting of a malignant tumor, a precancerous tumor, a benigntumor, infections, pneumonia, a necrotic cell, a blood clot and anycombination thereof. At least one irregularity in the tissue's cells mayalso be recognized by comparing the emerging heat transfer indexes to apredetermined range of slopes which are suspected to be the result ofirregular biomechanical-thermal properties in a tissue. In otherembodiments, the heat transfer indexes may be compared to a baseline ofhealthy tissues or other tissues comprising at least one irregularity inthe tissue's cells, whether extracted from the same patient or from aplurality of other examined individuals.

In several embodiments, thermal analysis software 103 is configured tocalculate a ratio between the distinctive heat transfer index of thesuspected area to the heat transfer index of the surrounding tissuearea. This ratio can then be compared to other ratios taken from otherexamined individuals.

Display means 104 may illustrate a numerical or graphical presentationof the gradient temperatures, the heat transfer maps, the thermal dataimages, at least one irregularity in the tissue's cells markings, atleast one irregularity in the tissue's cells border, the patient'spersonal parameters and the like.

The procedure includes heating and/or cooling application to theexamined area, forcing the tissue to transfer heat, followed bymonitoring the tissue's heat transfer and cooling by a thermal sensorscreening sampling of multiple thermal images, until full coverage ofexamined tissue surface is reached, and finally constructing temperatureprofile in relation to time and location, as measured during the test(marking any irregularities).

In some embodiments, the device is directed to examining the lungs. Insuch an embodiment, heat convection by inhalation of hot gas, such asatmospheric air, oxygen, helium, hydrogen, nitrogen, carbon dioxide orany other inhalable gas would supply a heat application to at least aportion of the lung area, from the symphonies to the alveolus. Thethermal potential created between the surface lung tissues and theinternal ones would transfer heat to the inner tissues. There, it wouldbe absorbed and spread by the internal layers. This is done due toseveral heat transfer mechanisms found in biological tissues andconduction. This process would eventually balance at steady state. Sincecancerous tissues vary in thermal properties from healthy ones andspecifically the thermal diffusion, it would stand out of the healthyenvironment. Using the thermal camera images taken throughout theprocedure, heat transfer index analysis is made. Area temperaturemapping (According to the camera's resolution), at different times(according to the camera's sampling rate—FPS) is depicted. This maps thediffusion properties, revealing the abnormal areas. Finally a threedimensional map of the examined tissue or organ is constructed, markingthe suspected areas.

Reference is now made to FIG. 2, illustrating a high level overview of apreferred embodiment of the system disclosed by the present invention.The system disclosed by the present invention may comprise mechanicalspeculum 110, in order to gain access to examined tissue 10 which me bean inner tissue area, such as the cervix. After gaining access toexamined tissue 10, scanner module 120 is operated. The module comprisesa heat/cool source 121, scan unit 122, thermal sensor 123, and mayfurther comprise spatial positioning means 125, which could be in anon-limiting example a CCD camera, a thermal camera, a laserrangefinder, or an ultrasound scanner, and may also comprise at leastone environmental sensor adapted to measure various parameters of theambient environment where the examination takes place, and this sensormay be, in a non-limiting example a thermometer, a hygrometer, aphotodetector and any combination thereof.

In an embodiment of the present invention, the heat/cool source 121could be any device which is configured to apply heat to the surfacearea of an examined tissue in a manner of advection, convection,conduction, radiation or any combination thereof. In a similar manner,cooling may be conducted by using a device which is configured to removeheat from the surface area of the tissue, in the manner of advection,convection, conduction, radiation or any combination thereof. Radiationmay be applied in any wave length.

Thermal sensor 123 refers to any device providing detection of thermalenergy in a resolution of time and space, and producing thermal imagedata. Preferably, thermal sensor 123 is an IR sensor, but not limited toit, and thermal sensor 123 may also be a mercury-in-glass thermometer,pill thermometer, liquid crystal thermometer, thermocouple, thermistor,resistance temperature detector, silicon bandgap temperature sensor andany combination thereof.

In some embodiments, thermal image data can be image processed by anobject recognition module, it can be correlated with data from otherimaging modalities and any combination thereof. The other imagingmodality can be, but not limited to, a camera image, a CT scan image, anMRI image, an ultrasound image, and any combination thereof. By thismeans, coordinated locations suspected of containing at least oneirregularity in the tissue's cells can be more accurately identified. Insome embodiments, the system can correlate at least one thermal imageand at least one image from at least one spatial positioner to betteridentify the locations of any irregularities.

Thermal image data and any other data is then communicated to thesoftware module 130, which comprises data collector submodule 131, dataanalyzer submodule 132 and results submodule 133. Software module 130comprises the thermal analysis software 103 and results in temperaturemeasurements which are subjected to mathematical manipulations includingderiving a first, second or third derivative of the change intemperature over time, resulting in the heat transfer index. This indexmay further be used to construct the heat transfer map or the thermaldiffusivity image exhibiting the suspected areas of at least oneirregularity in the tissue's cells. Data collector 131 is found inoperative communication with scanner module 120, and comprises all thedata available from module 120. Data analyzer 132 is found incommunication with data collector 131 and extracts the relevant datarequired for the heat transfer index analysis. Results 133 is found incommunication with data analyzer 132 and contains analyzed data fromcervical scanner 120.

In some embodiments, image processing by an object recognition module,correlation with images from other modalities and any combinationthereof can be done with the thermal diffusivity image.

The results 133 data, the analysis data of data analyzer 132 and the rawdata of data collector 131 are then preferably transferred to database140. This database may be found in the same electronic device assoftware module 130, or may be in a different device, and even possibly,the data is wirelessly transmitted to database 140 which is found at adifferent location. Database 140 may comprise various submodules, and inthe illustrated embodiment it comprises personal data submodule 141,global data submodule 142, update submodule 143 and extract submodule144.

Personal data 141 comprises personal patient parameters which maycontain sex, age, smoking habits, drinking habits, number of births,height, weight, blood pressure, diabetes state, medical history,relatives' medical history, patient's previous heat transfer index andany combination thereof

Global data 142 may comprise data relating to examined tissues or organsin other tissues and/or in other individuals. Preferably global data 142contains a database of examinations of a plurality of tissues (aplurality of tissues from a single individual, or a plurality of tissuesfrom a plurality of individuals whose data has been recorded), accordingto the method as recited in the present invention. This databasecollectively provides a heat transfer index baseline according to whichan immediate examination is referred to. Global data 142 may compriseraw data taken from the scanner module, at least partially analyzed dataand/or results data. It may also contain personal information related tothe examined individuals participating in the baseline database.Preferably, global data provides the ratio between healthy tissues andtissues exhibiting at least one irregularity in the tissue's cells. Theratio may then be compared between the patient and a database containingsuch ratios from other examinees. The comparison between the patient'sratio and the global data's ratios will enable a better identificationof the irregularity in the tissue's cells, as well as the severity ofthe medical condition and the malignancy status.

Update 143 provides an updated analysis of the heat transfer indexresults 133 derived from scanner module 120, in view of the baselinedata of global data 142. Extract 144 provides the finalized analysis ofthe heat transfer index results, after being compared to the baselinedata. The baseline gradient temperature may refer to healthy tissues, ormay refer to any tissue having at least one irregularity in the tissue'scells. Global data 142 may comprise a plurality of databases relating tovarious tissue conditions, and comparison to the appropriate databasemay be determined, inter alia, according to personal data 141.

The final results of the analyzed tissue heat transfer provided bydatabase module 140 are then transferred to the user interface module150, which preferably comprises processor 151 and display 152. Userinterface 150 enables both data representation and data input by a user,where user of the system provided by the present invention enters anydata which is relevant to the analysis of the heat transfer index. Inaddition, the user may decide which output will be presented to him onthe display and in which manner.

Reference is now made to FIG. 3, illustrating a high level overview of apreferred embodiment of the method disclosed by the present invention.Preferably the method is conducted on the examined individual, if neededby creating access 210 to the suspected tissue, using device such as, ina non-limiting example, a mechanical speculum. After gaining access tothe suspected area, at least a portion of its surface undergoes heatingand/or cooling 220. The elevation/reduction in tissue temperature ismonitored and if the temperature has not reached the desired value 230,then a better access 210 and/or re-heating/cooling 220 is repeated. Ifthe temperature has reached the desired value, then thermal scanning 240is conducted next.

Thermal scanning 240 includes the use of a thermal sensor, such aspreferably an IR sensor, but could also include a mercury-in-glassthermometer, pill thermometer, liquid crystal thermometer, thermocouple,thermistor, resistance temperature detector, silicon bandgap temperaturesensor and any combination thereof, and the heat transfer indexanalysis, resulting in a heat transfer map. If no distinctive heattransfer indexes emerge 250, i.e. the heat transfer map is homogenousand normal tissue status is displayed 30, showing a numerical orgraphical representation of healthy results. If on the other hand,inhomogeneous regions are suspected to be in the heat transfer map, thedata is preferably compared to a database 260. The database comprises abaseline derived from various examinations of other tissues and/or otherexamined individuals, as depicted in FIG. 2. According to the comparison260, it can be determined if the tissue is cancerous/precancerous 270,in addition to providing an estimate of the severity of the medicalcondition, the extent of at least one irregularity in the tissue's cellsor the malignancy status of the tumor. Such a comparison may be to theheat transfer index itself, or to the ratio between the heat transferindex exhibited by the healthy tissue to the heat transfer indexexhibited by the suspicious tissue. If it is, then marking is displayedfor the cancerous region 20. If the comparison does not result in cancersuspicious tissue, other pathologies may be diagnosed 280, might be withthe use of other baselines. If other pathologies are identifies, thenmarkings of the found pathological region is displayed 21. If no cancer,and no other pathology are found, then normal tissue status is displayed31.

In some embodiments of the system, at least one map of the examined areais generated. The map can be a two-dimensional map of a narrow region, aslice of the subject, or a three-dimensional map of a portion of asubject. The map can be of at least one tissue parameter or of atime-resolved tissue parameter, where the tissue parameter can beselected from a group consisting of: thermal conductivity coefficient,thermal diffusion coefficient, heat capacity, density, heat loss due toblood perfusion, blood temperature, heat convection index, metabolicheat source and any combination thereof. At least one map can be of theanalyzed time-resolved thermal data, for example by color-mapping theresultant time resolved thermal index, I.

According to an embodiment of the present invention, the method can alsobe applied to diagnosis based on comparison of the analyzed results to abaseline. This baseline could be any tissue which was processed usingthe method proposed in the present invention, i.e. any healthy ormalignant tissue, which has been applied with heating or cooling, andbeen scanned for temperature gradient profiling. The temperaturegradient profile, and the resulting heat transfer index, of the examinedtissue can be compared with the temperature gradient profile, and theresulting heat transfer index, of the baseline tissue. Identification ofsimilar patterns will enhance the likelihood of correct diagnosis and,therefore, selection of suitable treatment routines.

In various embodiments of the present invention, the heat transfer indexis normalized to provide a scale, preferably a numerical scale, whichhas a range between 1 and 10, wherein a higher value indicates a higherseverity of the medical condition of an irregularity in the tissue'scells, or a later cancer stage. A value of 0 may indicate healthytissue.

Reference is now made to FIGS. 4-7, demonstrating results of a firstexperimental set up which includes six experiments conducted on six celltypes cultures. Various cell types are compared with regards to theirthermal properties. As shown in FIG. 4, the compared cell types are:lung tissue, including normal tissue (fibroblasts) and two types ofcancerous tissue (H1299 and 549) and kidney tissue, both normal tissue(AK-epithelial cells) and cancerous tissue (Wilm's tumor fromexografts).

FIG. 5A shows the locations on the plates of FIG. 5B of the cells of thetypes listed above and in FIG. 4, while FIG. 5B shows an example of thetemperatures of the cells on the plates during cooling.

FIG. 6 shows the differential cooling of the normal kidney tissue (uppercurve) vs. the Wilm's tumor tissue (lower curve). The normal tissue bothheats more and cools faster than the Wilm's tumor tissue. FIG. 7 showsthe first differential of the curves in FIG. 6, where the upper curve isfor the normal tissue and the lower curve for the Wilm's tumor tissue.

FIG. 8 exemplifies the data obtained and analyzed, as collected over atissue taken from cured swine meat. FIG. 8A shows an image obtained byspatial positioner, i.e. a camera, while FIG. 8B illustrates thermaldata collected by a thermal sensor, in this example an IR sensor. Theimage shows the analyzed time-resolved thermal data by color-mapping theresultant time resolved thermal index, I. Background has been removed bysetting a threshold index I to present. The index I was calculatedaccording to the following:T=a+b*exp(−I*t)where a and b are constants and T is temperature.

The graphical presentation shows a proof of concept, illustrating thehigh power of the algorithm disclosed by the present application indistinguishing between tissues by exploiting their recovery from activethermomodulation.

FIG. 9 presents thermal decay profiles of two coordinated locations, onehaving a cancerous cell sample and the other having a healthy cellsample, illustrating that the difference in the apparent decay trend andin the calculated decay rate constant is significant. In this example,the decaying temperature measurements were fitted to the followingformulas:T ₁(t)=29.24+(14.74*exp(−0.0148*t))T ₂(t)=29.06+(12.91*exp(−0.0135*t))where T₁ gives the temperature decay curve for the normal tissue and T₂gives the temperature decay curve for the cancerous tissue, with thecancerous tissue, which is cooler than the normal tissue, returning toambient more slowly than the cancerous tissue. Thus, a significantdifference between the index, I₁, of T₁ and the index, I₂, of T₂ isshown as:I ₁ /I ₂=(−0.0148/−0.0135)=1.09i.e. approximately a 10% difference. This example illustrates that acalculated ratio between two thermal transfer indexes I, which isgreater than I_(irr)=10% corresponds with an irregularity in thetissue's cells.

The tested tissue is thermally excited by heating or cooling the tissuesurface, and is then carefully monitored for heat spread and absorption.Using infrared sensors, thermal surface images are obtained in varioustime intervals. Analyzing the temperature variation from the images, inrelation to time and position can reveal points of irregularity, whichsuggest pathological tissue.

Without wishing to be bound by theory, the concept of using thermalanalysis based on thermal diffusivity changes for finding anyirregularities is already successfully implemented in the field ofmaterial analysis. Industrial and research facilities applynon-destructive tests (NDT) for a variety of materials (such as metals,polymers, concrete, composite materials and others) using infraredactive analysis. The tested material is thermally excited by heating thesurface, and carefully monitored for heat conduction. Using infraredsensors, thermal surface images are obtained for different samplingtimes. Analyzing the temperature profile from the images, in relation totime and position can reveal irregularities. These might be cracks orany other flaws in the material, which are discovered due to differencesin their thermal properties compared to homogeneous material.

Hereby is the “Penne's equation”, a widely accepted temperatureprofiling equation for biological tissues:

${\rho C\frac{\partial T}{\partial t}} = {{\nabla\left( {k{\nabla T}} \right)} + q + A_{0} - {b\left( {T - T_{b}} \right)}}$where:

$q\left\lbrack \frac{W}{m^{3}} \right\rbrack$External heat source;

$A_{0}\left\lbrack \frac{W}{m^{3}} \right\rbrack$Metabolic heat source

$b\left\lbrack \frac{W}{m^{3}\mspace{11mu}{^\circ}\;{C.}} \right\rbrack$Heat loss due to blood perfusion; T_(b) [° C.]—Blood temperatureT [° C.]—Tissue temperature;

$\rho\left\lbrack \frac{kg}{m^{3}} \right\rbrack$Density

$C\left\lbrack \frac{J}{{kg}\mspace{11mu}{^\circ}\;{C.}} \right\rbrack$Heat capacity;

$k\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$Thermal conductivity factor

Biological tissues behave much like a homogenous solid whose thermalproperties are defined mostly by its water content. In addition, thereis a dependency of the properties on tissue temperature.

Different studies have shown that there is a temperature rise ofapproximately 1 degree Celsius in cancer tumor compared a healthyneighboring tissue. This is due to enhanced metabolic activity,accelerated growth mechanisms and massive blood vessel usage of thetumor. It is therefore expected to find a temperature of 380 Celsius ina lung tumor opposed to normal 37 Celsius in normal lung tissue. Thischange of temperature supports the premises that cancer cells havedifferent thermal properties. This of course enables the diagnostic ofsuch cells using active thermal imaging.

Studies include “Modeling Temperature in a Breast Cancer Tumor forUltrasound-Based Hyperthermia Treatment” by Brian Ho et al.; Strom etal., Cancer research, 1979; “Introduction to NDT by Active InfraredThermography” by X. Maldague; “Thermal Properties” by Holmes; and“Tissue Thermal Properties and Perfusion” by Jonathan W. Valvano, whichare incorporated herein as a reference.

The thermal conductivity factor “k” for human tissues has been testedbefore, however, it was not categorized to different lung tissuesgroups. Moreover the data that do exist does not mention the lung tissuetype tested. As in many human tissues, the lung tissue contains a largeamount of water. This makes its thermal properties very close to thoseof water and in particular the conductivity factor.

According to McIntosh and Anderson's literature survey taken in 2010, inwhich several conductivity factor where tested (McIntosh and Anderson,Biophysical Reviews and Letters, 2010, incorporated herein as areference), average values can be calculated for the factor. It ishereby presented:

${Maximum}\mspace{14mu}{value}\text{:}\mspace{14mu}{0.28\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack}$${Minimum}\mspace{14mu}{value}\text{:}\mspace{14mu}{0.48\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack}$${Avrage}\mspace{14mu}{value}\text{:}\mspace{14mu}{0.38\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack}$

The lung's “K” factor varies significantly according to the subject'sage. Values could change from 0.3 in a child's to 0.55 in a grown manwith a lung disease.

The thermal diffusion is a property subjected to changes according tothe three previously mentioned properties in this manner:

$\alpha = \frac{K}{pC}$Whereas:

$\rho\left\lbrack \frac{kg}{m^{3}} \right\rbrack$Density;

$C\left\lbrack \frac{J}{{kg}\mspace{11mu}{^\circ}\;{C.}} \right\rbrack$Heat capacity;

$k\left\lbrack \frac{W}{m\mspace{11mu}{{{^\circ}C}.}} \right\rbrack$Thermal conductivity factor

The experiment is to prove the differences in thermal diffusion betweena healthy tissue and a cancer one, and that it is large enough to besuccessfully identified as an irregularity.

Example 1

The experimental set up used to evaluate the invention is comprised oftwo stages. The second stage is designed to achieve greater accuracy andelaboration of the results obtained in the first stage, in addition tohandling experimental issues and difficulties arising in the firstexperimental stage. The second stage was conducted in view of theresults obtained in the first. Experimental design goes as follows:

Image capturing of all cell cultures; Laboratory conditions take intoaccount: (a) Neutralizing disturbances; (b) Constant temperature,registration of any alterations. (c) Registration of humidity values.

Camera set up: Control set up—heating; Control set up—cooling; Conductexperiments using heating; Conduct experiments using cooling.

Example 2

The system of the present invention can be configured as a ‘decisionsupport’ system, informing a user such as a clinician as to whether apositive CT result is a cancer (true positive) and requires furtherinvestigation, or whether the positive CT result is a false positive.

With the system of the present invention, the results are immediate, donot involve radiation risks and are independent of an expert's eye. Thetest is computerized and automatic, with no need for a long, expensiveanalyzing stage.

As disclosed above, the technology is based upon analysis of thetemperature decay profile and measurement of heat diffusion in the lung.It is well known that the density of cancerous cells is higher than thatof normal cells, their shape is different and their nuclei are enlarged.These differences cause a fundamental change in the thermal propertiesof the cells. The planned operating principle—short heating followed bytracking diffusion of heat into the tissue and absorption of heat in thetissue.

An IR camera can be directed through the tumor from outside the body (orfrom the inside of the lung) and can be scanned during the examination.Thermal excitation can be provided by inhalation of a hot gas, such ashot hot gas, such as atmospheric air, oxygen, helium, hydrogen,nitrogen, carbon dioxide or any other inhalable gas, from a dedicatedballoon, by irradiating the tissue by light (such as, but not limitedto, infrared light, visible light or ultraviaolet light), or both. Afterapplication of the heat, the heat source can be deactivated and, fromthat moment, video images can be taken at a high acquisition rate forseveral minutes. During this time, the tissues will cool to atemperature close to their default, unheated, temperatures.

An analysis of the temperature decay profile at every point on thesurface can be executed in real time or after a delay. For non-limitingexample, the analysis can take place after data acquisition is complete.Preferably, any delay in analysis will be short, typically no more thana few minutes. A comparison can be carried out between adjacent pointsin the image (according to the number of pixels) and a furthercomparison for the database can be collected. The measurements can beprocessed to create a map that will mark suspected cancerous areas, ifany, on a display.

The method comprises testing the tissues' response to thermal excitationover a short period of time, and therefore can distinguish betweencancer and other pathologies such as benign growths or necrosis as aresult of cancer treatment and surgical removal.

The evaluation can be performed with high precision because the testsearches for discontinuities on a continuous surface pursuant to heattransfer in the tissues.

Unlike alternatives currently available, the test does not expose apatient to harmful radiation, can reduce the quantity of falsepositive/false negative results obtained and will save the health systemtime and money as there is no need for a medical specialist to performthe test or for an expert to decode the results.

The system's principal components:

-   -   A dedicated inhaled excitation device.    -   An IR camera, either outside the body or inside the lungs.    -   A decoding system, which includes both software and a user        interface.    -   Optionally, a central server including a cumulative database        related to the patient's medical records, to which new data can        be added and re-analysis of the data can be carried out to        provide improved and updated diagnosis on a timely basis.

Example 3

A simulation of a method of generating a thermal diffusion image isdemonstrated on a horizontal slice of a human thorax (chest), whichincludes the lungs and the heart. FIG. 10 shows a CT image of a normalhuman thorax (1000), showing the heart (1010), spine (1020), lungs(1030), and the bones (1040), muscles (1050) and fat (1060). These havebeen overlaid with lines indicating the simplified shapes for the organswhich will be used in the simulation. The spine (1020) is simulated by atriangle, the heart (1010) by an oval, with the inner and outer limitsof the bone (1040), muscle (1050) and fat (1060) being indicated byconcentric ovals. The lungs (1030) occupy the space between the oval ofthe heart (1010) and the triangle of the spine (1020) as inner limits tothe lungs and the inner perimeter of the bone (1040) as the outer limitsto the bone.

FIG. 11 shows the simplified shapes of the organs (1100), without the CTscan. In FIG. 11, the heart (1010) is indicated by the oval filled withright diagonal lines, the spine (1020) by the triangle with horizontallines, the lungs (1030) by left diagonal lines, the bones (1040) by thedotted region outside the lungs, the muscles (1050) by the grey region,and the fat (1060) by the outermost, diamond-filled region. The width ofthe slice, side-to-side, is approximately 30 cm.

Table 1 shows the physical parameters used in the simulation.

TABLE 1 Physical parameters used in the simulation Thermal Heat Conduc-Generation tivity Specific Heat Perfussion Rate Tissue Density k c_(p)(ml/ Q Type (kg/m³) (W/(m K)) (J/(kg K)) (min gm)) (W/m³) Air 1.2050.0257 1005 — 0 Lung 427 0.38 3886 0.04  600 Cortical 1460 0.295 12440.027  0 Bone Cancellous 1460 0.295 2292 0.027  0 Bone Muscle 1103 0.493322 0.0009 684 Fat 909 0.21 2065 0.0002 58 Blood 1060 0.51 3651 — 0Heart 1086 0.55 3669 1.17  700 Tumor 1050 0.561 3852 0.009  5000

FIG. 12 illustrates a simulated steady-state heat distribution in achest with a growth (1210) in the lungs. The center of the growth is atan x-coordinate of about −0.055 m. The initial conditions for thesimulation were a uniform temperature of 37° C. (310 K), with a heattransfer coefficient at the skin boundary of about 10 and radiative heattransfer from the skin. Of the normal tissue, the heart is the hottestpart of the simulation, at approximately 310 K, while the lungs, atapproximately 304-306 K, are the coolest, while the bone and muscle areabout 308-309 K. The skin is at about 303 K, with the temperature in thefat rising form about 303 K to about 306 K. The growth (1210), at about310 K, is clearly seen on the left side of the figure.

FIG. 13 illustrates the effect of inhaling a hot gas on the temperaturedistribution inside the chest. In this simulation, the gas was at atemperature of 50° C. (323 K) and was “inhaled” (provided to the lungsas a heat generation source) for 30 s.

FIG. 14 illustrates the change in the temperature profile as measuredoutside the chest, for example by an imaging device such as an IRcamera, as the chest cools back to its steady state temperature profileafter heating. The uppermost curve (1610) illustrates the temperatureprofile immediately after completion of inhalation of the hot gas, whilethe lowermost curve (1620) illustrates the steady-state temperatureprofile. The anomaly (the growth 1210) is clearly present, although itscenter appears to be at about −0.03, rather than the known centralposition of about −0.55.

These simulations show that the presence and approximate location of ananomaly can be determined from outside the chest, that heating frominside the lungs materially affects the temperature profile inside thebody, and that this change in internal temperature profile isdeterminable from outside the body.

While the invention is susceptible to various modifications andalternative forms, specific embodiments thereof have been shown by wayof example in the drawings and the above detailed description. It shouldbe understood, however, that it is not intended to limit the inventionto the particular forms disclosed, but on the contrary, the intention isto cover all modifications, equivalents, and alternatives falling withinthe spirit and scope of the invention as defined by the appended claims.

The invention claimed is:
 1. A method of detecting and diagnosing of atleast one irregularity in an examined tissue, characterized by steps of:actively thermomodulating at least a portion of said examined tissue,said active thermomodulation selected from a group consisting ofheating, cooling and any combination thereof, said activethermomodulation applied according to a pre-determined protocol selectedfrom a group consisting of: in a continuous manner, in a pulsed mannerand any combination thereof; collecting time-resolved thermal data atpredetermined time intervals over time t, for a plurality of coordinatedlocations of at least a portion of said examined tissue; calculatingaccording to said time-resolved thermal data, (a) a thermal transferindex, I, for each of said plurality of coordinated locations; and (b) aratio between each said thermal transfer index for each of saidplurality of coordinated locations; and wherein at least one of thefollowing steps is being held true: determining tissue at least one ofsaid plurality of coordinated locations as irregular if, for said atleast one of said plurality of coordinated locations, said I is greaterthan a measured value I of a baseline tissue; and determining tissue ata first coordinated location as irregular if, for at least two of saidplurality of coordinated locations, a ratio between a first I_(first)for a first coordinated location and a second I_(second) for a secondcoordinated location is greater than a predetermined value I_(iir),further wherein said processor is configured to generate a visualpresentation of said coordinated locations according to said I or aninferential thereof, further comprising a step of defining said Iaccording to the following formula:T=a+b*exp(−I*t) where T is temperature at said time t and a and b areconstants.
 2. The method according to claim 1, further comprising atleast one of the following steps: selecting said at least oneirregularity from a group consisting of a malignant tumor, aprecancerous tumor, a benign tumor, neoplasm, an infection, pneumonia, anecrotic cell, a blood clot and any combination thereof; selecting saidexamined tissue from a group consisting of lung tissue, skin, cervicaltissue, ear tissue, nose tissue, throat tissue, oral tissue, esophagealtissue, stomach tissue, intestinal tissue, colon tissue, rectal tissue,kidney tissue, uterine tissue, urinary tract tissue, bladder tissue,prostate tissue, eye tissue, and any combination thereof; and selectingsaid time t to be in a range from about 10 ns to about 10 min.
 3. Themethod according to claim 1, further comprising steps of collecting saidthermal data using at least one sensor and of selecting said at leastone sensor from a group consisting of: an IR sensor, Ultrasound amercury-in-glass thermometer, pill thermometer, liquid crystalthermometer, thermocouple, thermistor, resistance temperature detector,silicon bandgap temperature sensor and any combination thereof.
 4. Themethod according to claim 1, further comprising at least one of thefollowing steps: producing at least one heat diffusion image of at leasta portion of said examined tissue prior to said active thermomodulation;image processing said at least one heat diffusion image by at least oneobject recognition module, thereby identifying coordinated locationssuspected of containing at least one said irregularity; and providing atleast one spatial positioner selected from a group consisting of avisible light imaging means, a CCD camera, an ultrasound scanner, athermal camera, a laser rangefinder and any combination thereof, andcorrelating said at least one heat diffusion image and at least oneimage from said at least one spatial positioner.
 5. The method accordingto claim 1, further comprising a providing a normalization step, atleast one of the following being held true: said normalizing stepcomprises normalizing said I to a predetermined scale, a higher value onsaid scale indicating a higher severity of the medical condition of saidat least one irregularity; said normalizing step is selected from agroup consisting of correcting for ambient temperature, correcting forambient humidity, correcting for ambient electromagnetic radiation andany combination thereof; and said heat transfer index is normalized withpatient parameters selected from a group consisting of sex, age, smokinghabits, drinking habits, number of births, height, weight, bloodpressure, diabetes state, medical history, relatives medical history,patients previous heat transfer index and any combination thereof. 6.The method according to claim 1, further comprising steps of selectingsaid active thermomodulation from a group consisting of advecting heat,convecting heat, conducting heat, irradiating and any combinationthereof; and of selecting said active thermomodulation device from agroup consisting of hot fluid inhalation, cold fluid inhalation, hotfluid application, cold fluid application, halogen lamp exposure, LEDlight exposure, xenon lamp exposure, flash lamp exposure, incandescentlamp exposure, IR emission, electromagnetic vibration heating,mechanical vibration heating, positioning a heatable solid, positioninga coolable solid, positioning a heatable patch, positioning a coolablepatch, pharmaceutical temperature modification, chemically inducedheating, chemically induced cooling and any combination thereof.
 7. Asystem for detecting, diagnosing and guiding treatment of at least oneirregularity in an examined tissue, comprising: an activethermomodulator configured to apply to at least a portion of saidexamined tissue a member of a group consisting of: heating cooling andany combination thereof, said active thermomodulation applicableaccording to a pre-determined protocol selected from a group consistingof: in a continuous manner, in a pulsed manner and any combinationthereof; at least one thermal sensor configured to provide at least onesignal related to temperature in at least a part of said at least aportion of said examined tissue; and a processor configured to executeinstructions comprising: collect time-resolved thermal data, atpredetermined intervals over time t, of a plurality of coordinatedlocations of at least a portion of said examined tissue by conversion ofsaid signal from said at least one thermal sensor to time-resolved andspatially-resolved thermal data; and calculate, according to saidtime-resolved thermal data, (a) a thermal transfer index, I, for each ofsaid plurality of coordinated locations; and (b) a ratio between eachsaid thermal transfer index for each of said plurality of coordinatedlocations; and wherein at least one of the following is being held true:if, for at least one of said plurality of coordinated locations, said Iis greater than a measured value I of a baseline tissue, determiningtissue at said least one coordinated location as irregular; and if, forat least two of said plurality of coordinated locations, a ratio betweena first I_(first) of a first coordinated location and a secondI_(second) of a second coordinated location is greater than apredetermined value I_(irr), determining tissue at said firstcoordinated location as irregular; further wherein said processor isconfigured to generate a three-dimensional thermal map of said at leasta portion of said examined tissue, wherein said I is defined accordingto the following formula:T=a+b*exp(−I*t) where T is temperature at said time t and a and b areconstants.
 8. The system according to claim 7, wherein at least one ofthe following is held true: said at least one irregularity is selectedfrom a group consisting of a malignant tumor, a precancerous tumor, abenign tumor, neoplasm, an infection, pneumonia, a necrotic cell, ablood clot and any combination thereof; said examined tissue is selectedfrom a group consisting of lung tissue, skin, cervical tissue, eartissue, nose tissue, throat tissue, oral tissue, esophageal tissue,stomach tissue, intestinal tissue, colon tissue, rectal tissue, kidneytissue, uterine tissue, urinary tract tissue, bladder tissue, prostatetissue, eye tissue, and any combination thereof; and said time t isselected to be in a range from about 10 ns to about 10 min.
 9. Thesystem according to claim 7, wherein said at least one sensor isselected from a group consisting of: an IR sensor, ultrasound amercury-in-glass thermometer, pill thermometer, liquid crystalthermometer, thermocouple, thermistor, resistance temperature detector,silicon bandgap temperature sensor and any combination thereof.
 10. Thesystem according to claim 7, wherein at least one of the following isheld true: at least one heat diffusion image of at least a portion ofsaid examined tissue is producible prior to said activethermomodulation; at least one coordinated location suspected ofcontaining at least one irregularity is identifiable by means of imageprocessing of said at least one heat diffusion image by at least oneobject recognition module; and said system additionally comprises atleast one spatial positioner selected from a group consisting of: avisible light imaging means, a CCD camera, a skin dermoscope, amicroscope, an ultrasound scanner, a thermal camera, a laser rangefinderand any combination thereof, and said processor additionally comprisesinstructions configured to correlate said at least one heat diffusionimage and at least one image from said at least one spatial positioner.11. The system according to claim 7, wherein said computer processoradditionally comprises instructions to provide a normalization step, atleast one of the following being held true: said normalizing stepcomprises normalizing said I to a predetermined scale, a higher value onsaid scale indicating a higher severity of the medical condition of saidat least one irregularity; said normalizing step is selected from agroup consisting of correcting for ambient temperature, correcting forambient humidity, correcting for ambient electromagnetic radiation andany combination thereof; and said heat transfer index is normalized withpatient parameters selected from a group consisting of sex, age, smokinghabits, drinking habits, number of births, height, weight, bloodpressure, diabetes state, medical history, relatives medical history,patients previous heat transfer index and any combination thereof. 12.The system according to claim 7, wherein said active thermomodulation isselected from a group consisting of advecting heat, convecting heat,conducting heat, irradiating and any combination thereof; and saidactive thermomodulation device is selected from a group consisting ofhot fluid inhalation, cold fluid inhalation, hot fluid application, coldfluid application, halogen lamp exposure, LED light exposure, xenon lampexposure, flash lamp exposure, incandescent lamp exposure, IR emission,electromagnetic vibration heating, mechanical vibration heating,positioning a heatable solid, positioning a coolable solid, positioninga heatable patch, positioning a coolable patch, pharmaceuticaltemperature modification, chemically induced heating, chemically inducedcooling and any combination thereof.
 13. A non-transitory computerreadable medium (CRM) having instructions which, when implemented by oneor more computers, causes said one or more computers to: collecttime-resolved thermal data, at predetermined intervals over time t, of aplurality of coordinated locations of at least a portion of saidexamined tissue by conversion of said signal from said at least onethermal sensor to time-resolved and spatially-resolved thermal data; andcalculate, according to said time-resolved thermal data, (a) a thermaltransfer index, I, for each of said plurality of coordinated locations;and (b) a ratio between each said thermal transfer index for each ofsaid plurality of coordinated locations; and wherein at least one of thefollowing is being held true: if, for at least one of said plurality ofcoordinated locations, said I is greater than a measured value I of abaseline tissue, determining tissue at said least one coordinatedlocation as irregular; and if, for at least two of said plurality ofcoordinated locations, a ratio between a first I_(first) of a firstcoordinated location and a second I_(second) of a second coordinatedlocation is greater than a predetermined value I_(irr), determiningtissue at said first coordinated location as irregular, wherein said Iis defined according to the following formula:T=a+b*exp(−I*t) where T is temperature at said time t and a and b areconstants.
 14. The CRM according to claim 13, wherein at least one ofthe following is held true: said at least one irregularity is selectedfrom a group consisting of a malignant to mor, a precancerous tumor, abenign tumor, neoplasm, an infection, pneumonia, a necrotic cell, ablood clot and any combination thereof; said examined tissue is selectedfrom a group consisting of lung tissue, skin, cervical tissue, eartissue, nose tissue, throat tissue, oral tissue, esophageal tissue,stomach tissue, intestinal tissue, colon tissue, rectal tissue, kidneytissue, uterine tissue, urinary tract tissue, bladder tissue, prostatetissue, eye tissue, and any combination thereof; and said time t isselected to be in a range from about 10 ns to about 10 min.
 15. The CRMaccording to claim 13, additionally comprising instructions configuredto execute at least one of the following: produce at least one heatdiffusion image of at least a portion of said examined tissue prior tosaid active thermomodulation; identify at least one coordinated locationsuspected of containing at least one irregularity by means of imageprocessing of said at least one heat diffusion image by at least oneobject recognition module; and correlate said at least one heatdiffusion image and at least one image from at least one spatialpositioner, said at least one spatial positioner selected from a groupconsisting of: a visible light imaging means, a CCD camera, anultrasound scanner, a thermal camera, a laser rangefinder and anycombination thereof.
 16. The CRM according to claim 13, additionallycomprising instructions configured to provide a normalization step, atleast one of the following being held true: said normalizing stepcomprises normalizing said I to a predetermined scale, a higher value onsaid scale indicating a higher severity of the medical conditionassociated with said at least one irregularity; said normalizing step isselected from a group consisting of correcting to ambient temperature,correcting to ambient humidity, correcting to ambient electromagneticradiation and any combination thereof; and said heat transfer index isnormalized with patient parameters selected from a group consisting ofsex, age, smoking habits, drinking habits, number of births, height,weight, blood pressure, diabetes state, medical history, relativesmedical history, patients previous heat transfer index and anycombination thereof.
 17. The CRM according to claim 13, wherein saidactive thermomodulation is selected from a group consisting of advectingheat, convecting heat, conducting heat, irradiating and any combinationthereof; and said active thermomodulation device is selected from agroup consisting of hot fluid inhalation, cold fluid inhalation, hotfluid application, cold fluid application, halogen lamp exposure, LEDlight exposure, xenon lamp exposure, flash lamp exposure, incandescentlamp exposure, IR emission, electromagnetic vibration heating,mechanical vibration heating, positioning a heatable solid, positioninga coolable solid, positioning a heatable patch, positioning a coolablepatch, pharmaceutical temperature modification, chemically inducedheating, chemically induced cooling and any combination thereof.